+

WO2008146942A1 - Method for production of phospholipid-containing functional material, and method for production of plasmalogen-type glycerophospholipid - Google Patents

Method for production of phospholipid-containing functional material, and method for production of plasmalogen-type glycerophospholipid Download PDF

Info

Publication number
WO2008146942A1
WO2008146942A1 PCT/JP2008/060120 JP2008060120W WO2008146942A1 WO 2008146942 A1 WO2008146942 A1 WO 2008146942A1 JP 2008060120 W JP2008060120 W JP 2008060120W WO 2008146942 A1 WO2008146942 A1 WO 2008146942A1
Authority
WO
WIPO (PCT)
Prior art keywords
plasmalogen
phospholipid
type
mass
poultry
Prior art date
Application number
PCT/JP2008/060120
Other languages
French (fr)
Japanese (ja)
Inventor
Yoshitaka Nadachi
Takehiko Fujino
Siro Mawatari
Osamu Kukino
Keiji Umeda
Original Assignee
Umeda Jimusho Ltd.
Institute Of Rheological Function Of Food Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umeda Jimusho Ltd., Institute Of Rheological Function Of Food Co., Ltd. filed Critical Umeda Jimusho Ltd.
Priority to JP2009516384A priority Critical patent/JP5774816B2/en
Publication of WO2008146942A1 publication Critical patent/WO2008146942A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/10Production of fats or fatty oils from raw materials by extracting
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/02Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from meat
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B13/00Recovery of fats, fatty oils or fatty acids from waste materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02WCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00Technologies for solid waste management
    • Y02W30/50Reuse, recycling or recovery technologies
    • Y02W30/74Recovery of fats, fatty oils, fatty acids or other fatty substances, e.g. lanolin or waxes

Definitions

  • the present invention provides a simple operation of a phospholipid-containing functional material useful as a functional food material, a pharmaceutical material, a cosmetic material, etc.
  • the present invention relates to a method for producing with good yield, and also relates to a plasmalogen type glyceport phospholipid. Background art
  • Lipid refers to a substance that has a long-chain fatty acid or a similar hydrocarbon chain in a molecule and exists in a living body or is derived from a living organism. This lipid can be classified into simple lipids and complex lipids. Simple lipids are composed of C, H, and O, and are generally soluble in acetone. The simple lipid triacylglycerol exists in an animal body as a reservoir of energy in adipose tissue. On the other hand, complex lipids are a group of lipids including phosphoric acid P and base N. Therefore, complex lipids consist of a hydrophobic part (fatty acid part) and a hydrophilic part (phosphoric acid or base part), exhibiting amphipathic properties. Generally, the simple lipid is soluble in acetone. In contrast, complex lipids are insoluble in acetone. Such complex lipids are constituents of biological membranes.
  • the complex lipid examples include (1) glyceline phospholipids [phosphatidylcholine (also known as lecithin), phosphatidylethanolamine, and the like. ], (2) Sphingolin lipids (sphingomyelin, ceramide dosylatin, etc.), (3) Glycosphingolipids (celebral mouthsides, sulfatides) TJP2008 / 060120 and Gandarioside belong. ), And (4) Groseroglycolipids (including those in which various cocoons are bound to diacylglycerol present in microorganisms and higher plants).
  • the (2) sphingolipid lipid and the (3) sphingoglycolipid are collectively referred to as sphingolipids.
  • the glyceport phospholipid is a general term for phospholipids having daricerophosphate as a skeleton, and includes phosphatidylcholine (lecithin), phosphatidylethanolanolin, diphosphitidylglycerol, and the like.
  • the nonpolar part is often an ester of a fatty acid, but there is also a plasmalogen type having a butyl ether bond.
  • This glyceport phospholipid is important as a component of biological membranes.
  • plasmalogen-type glycerophospholipid has been recently attracting attention as an antioxidant phospholipid because it is highly sensitive to vinyl ether bonds. It has been.
  • plasmalogen-type glyceport phospholipids have contributed to the oxidative stability of phospholipid membranes containing cholesterol by a mechanism different from that of ⁇ -tocopherol (vitamin E), an antioxidant component of cell membranes. (See, for example, “J. Lipid Res.”, Pp. 44, pp.
  • Such plasmalogen-type glyceport phospholipids are expected to prevent brain neuronal cell death in dementia, but in reality there are no sources that are safe and available in large quantities.
  • sphingomyelin in order to produce a relatively large amount of sphingomyelin from total lipids of foods, animal tissues, etc., it can be produced by elution stepwise in a column chromatography using a key acid or the like, or a solvent Manufactured by fractionation using a fractionation method. Both require complex procedures.
  • acetone is added to total lipids to precipitate complex lipids (phospholipids) (insoluble part), and the insoluble part is washed with ether to remove the glyceport phospholipids.
  • a method of fractionation is common. This fraction contains not only sphingomyelin but also glycosphingolipids such as cerebroside.
  • chicken skin phospholipids are rich in human sphingomyelin and plasmalogen-type dariceroline qualities.
  • Chicken skin is more useful as a raw material for human sphingomyelin compared to conventional raw material sources, but it contains a large amount of subcutaneous fat, sometimes exceeding 70% by mass, and this removal is extremely complicated. There's a problem. Chicken skin contains plasmalogen-type glycerophospholipid at the same level as human sphingomyelin, and the ratio of phosphatidylcholine (lecithin) and phosphatidinorethanolamine is significantly higher in the latter. is there.
  • the present inventors have eagerly developed a raw material that surpasses chicken skin, and the neutral lipid content in chicken meat, especially rice meat, is 30 to 70 times smaller than chicken skin, and it is a human sphingo.
  • the total content of myelin and plasmalogen-type glyceport phospholipids is several times greater.
  • the ratio of plasmalogen-type glyceguchi phospholipids to human sphingomyelin is more than 85% by mass
  • the composition ratio of plasma mouth type darisserophospholipid is 50-75% by mass in adult chickens, phosphatidylcholine in young chickens, and phosphatidylethanolamine in young chickens.
  • Plasmalogen-type phosphatidylcholine content is more than 30 times that of chicken skin, plasmalogen-type phosphatidylethanol in young chickens As a raw material for extraction of plasmalogen-type glyce mouth phospholipid (mixed in two kinds), plasmalogen-type phosphatidylcholine alone, and plasmalogen-type phosphatidylethanolamine alone, which is about twice as low as chicken skin, conventional examples We succeeded in finding a poultry fillet that was not cost-effective.
  • Adult fillet has 1 mass of total fat. /. 80% of them are phospholipids (neutral lipids are as small as 0.2% by mass), of which 45% by mass is plasmalogen-type glycerophospholipid (70% of which is plasmalogen-type) in phospha Chijirukori down) content in the raw breast 0s. 3 6 wt% (human type Sufi Ngomierin is slightly 0.0 3 mass 0/0), which is high, Rudake be processed as a main material Can be used to prepare functional foods with high added value.
  • phospholipids neutral lipids are as small as 0.2% by mass
  • poultry fillet along with thighs, has a high rate of meat collection, but because it is hard and crunchy and lacks juicy taste, it has been treated as low-use meat for a long time despite being healthy. Is receiving.
  • the annual meat culled from 100 million hens and 200,000 tons of minced meat is 15,000 tons, and it is strongly required to use them as domestic livestock. Disclosure of the invention
  • the present invention is a method for producing a functional material containing a large amount of plasmalogen-type glyce mouth phospholipid from poultry, particularly chicken fillet, and poultry fillet powder
  • An object of the present invention is to provide a method for producing a high-purity plasmalogen-type glyceport phospholipid from the above functional material with a simple operation and in a high yield.
  • the present inventors have obtained a functional material containing a large amount of plasmalogen-type glycerophospholipid by applying a specific process to poultry, particularly chicken fillet. It has been found that high-purity plasma-single-type glycepore phospholipids can be obtained efficiently by applying a specific process to poultry fillet powder, and based on this finding, the present invention is It came to be completed.
  • Poultry fillet (a) Mince process at low temperature and low oxygen atmosphere, (b) Paste process at low temperature using emulsifying dispersant (c) Low temperature drying A method for producing a functional material containing a phospholipid by transforming its shape by at least one process selected from the powdering processes of the above, comprising the sum of plasmalogen-type glycerophospholipid and sphingomyelin A phospholipid-containing functional material in which the content of the former in the amount is 85% by mass or more and the content of all phospholipids in the total lipid is 40% by mass or more is obtained. , Manufacturing method of functional material containing phospholipid,
  • the poultry are adult chickens (hereinafter sometimes referred to as abandoned chickens), and the former is 40% by mass or more in the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glycerophospholipid.
  • the poultry are adult broiler chickens and males, and the composition ratio of phosphatidinorecholine and phosphatidylethanolamine in plasmalogen-type glycerophospholipid is 50% by mass or more, (1) or the method described in (2), (5)
  • the poultry is a pleuler, and the latter is 50% by mass or more in the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glycepore phospholipid, as described in (1) or (2) above the method of,
  • the mixed solvent in step (B) contains n-hexane and acetone in a volume ratio of 4: 6 to 6: 4, and the amount used is 1 per 1 g of dry total lipid.
  • step (C) The water-soluble ketone solvent in step (C) is acetone, and the amount used is 10 to 30 mL per 1 g of the dried processed product of the soluble part obtained in step (B).
  • a plasmalogen-type glyce mouth which is useful as a functional food material, a pharmaceutical material, a cosmetic material, etc. from poultry, particularly chicken breast meat.
  • Plasmalogen-type glycerophospholipid, plasmalogen-type phosphatidylcholine simple substance, and plasmalogen-type phosphatidinoleethanolamine simple substance can be provided.
  • the poultry fillet shape-changing technology of the present invention and the pasting technology using emulsified and dispersed natural preparations are secondary functions that do not harden by heat treatment and maintain a succulent feeling with no by-product dripping even during freezing and thawing treatment. Therefore, the rice paste is extremely useful as a high-value-added food material for rice meat, and the present invention is the beginning of high-value-added rice meat, resulting in an increase in consumption. It is expected to contribute to health promotion.
  • Fig. 1 ELS D detection chromatogram of substances obtained from waste chicken fillet by each operation.
  • Fig. 2 ELSD detection chromatograms of substances obtained by each operation from waste chicken fillet of organic farming breeding hens (local chickens).
  • Fig. 3 ELSD detection chromatograms of substances obtained from each operation of commercially available young chicken breast meat.
  • the method for producing a phospholipid-containing functional material of the present invention comprises at least one step selected from the following steps ( a ), (b) and (c):
  • the production method of type glyceguchi phospholipid is composed of (A) step, (B) step and (C) step.
  • This step (a) is a mincing step in a low temperature / low oxygen atmosphere.
  • poultry fillet, especially chicken fillet if it has a skin, it is first skinned with a skinner treatment and then minced as usual. Lower the temperature, preferably 5. It is desirable to set the minced size and minced rate with priority given to avoiding local heat generation at the shredded portion after cooling to C or lower.
  • the minced meat and air exposure after mincing is minimized, and furthermore, with air purifiers to suppress air oxidation and bacterial infection, the room temperature is low, preferably in a semi-enclosed space of 15 ° C or less It is preferable to implement the treatment and its sealed packaging.
  • the obtained mince should be vacuum-packed with a high barrier film and stored refrigerated.
  • This step (b) is a pasting step at a low temperature using an emulsifying dispersant.
  • step (b) skinned fillet meat, preferably the meat that has been minced in the step (a) and vacuum-packed refrigerated and stored, preferably a non-enzymatic emulsion-dispersed natural preparation for protein foodstuffs.
  • Add an aqueous solution dissolved in an appropriate amount of water mix evenly with an appropriate cutter mixer or processor, and paste into a straight (straight type). It is recommended that the pasted type be prepared, and this paste be cooled with a high-parity film and then cooled and stored at a low temperature, preferably refrigerated. Refrigeration is possible for long-term storage.
  • This step (c) is a powdering step by low temperature drying.
  • step (c) skinned meat, preferably minced meat that has been refrigerated and stored in vacuum in the step (a), or in some cases, any of the straight type pastes in the step (b)
  • it is better to dry it in a minimally invasive manner with a commercially available freeze-drying device, and if necessary, pulverize it by low-temperature pulverization, and store this powder refrigerated under light shielding after vacuum packaging of a hybrid film.
  • the content ratio of the former in the total amount of plasmalogen glyce mouth phospholipid and sphingomyelin is 85% by mass or more, and The total content of phospholipids is 40% by mass or more.
  • the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glyce mouth phospholipid is 50% by mass or more of the former, and adult broiler chickens .
  • the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glycerin lipid is 50 masses in the former. / Is 0 or more, if a broiler, phosphine Achijiruko Li down and the component ratio of phosphatidyl ethanolamine plasmalogen type glycerin port Li down lipids, the latter 5 0 mass. / 0 or more.
  • This step (A) is a step of extracting the total fat from the poultry fillet powder, preferably the chicken fillet powder, and drying it.
  • poultry fillet powder is prepared.
  • the rice trimet meat may be dried and pulverized as it is, and minced and pasted as necessary. Then, it may be dried and powdered.
  • a powder that is refrigerated and stored in a shaded state after vacuum packaging of the high barrier film obtained in [Step (c)] is used.
  • the total lipid is extracted from the poultry fillet powder thus obtained using a solvent and dried to obtain a dry total lipid.
  • Solvents used for extraction of total lipids are those that are safe for food hygiene and have good extraction efficiency. As such a solvent, ethanol is particularly suitable. This extraction process can be performed according to a conventional method. However, ethanol-soluble non-lipid components are also extracted in this extraction process.
  • the extract can be obtained by removing the solvent using a rotary evaporator or by introducing nitrogen gas.
  • the dry total lipid obtained in the step (A) is extracted with a mixed solvent of an aliphatic hydrocarbon solvent and a water-soluble ketone solvent, and an insoluble portion and a soluble portion are extracted. It is the process of separating into.
  • examples of the aliphatic hydrocarbon solvent that is one component of the mixed solvent used for the extraction treatment of the dried total lipid include n-pentane, isopentane, n-hexane, isohexane, n Examples include monoheptane, isoheptane, cyclopentane, cyclohexane, etc., and these may be used alone or in combination of two or more. N Monohexane is preferred.
  • water-soluble ketone solvent which is the other component of the mixed solvent
  • acetone and / or methyl ethyl ketone can be used, and among these, acetone is preferable.
  • the ratio is preferably 4: 6 to 6: 4 in terms of volume ratio, and 4.5: 5.5 to 5.5: 4.5. Is more preferable.
  • the amount of the mixed solvent is usually about 10 to 30 mL per gram of dry total lipid.
  • the soluble part obtained in the step (B) is dried and then extracted with a water-soluble ketone solvent, and the insoluble part (hereinafter referred to as plasmalogen-type glyceport phospholipid) This is sometimes referred to as crude plasmalogen-type glycepore phospholipid.
  • the soluble part obtained in the step (B) is dried according to a conventional method.
  • a method of distilling off the mixed solvent in the soluble part using a rotary evaporator can be used.
  • the dried product obtained in this way is extracted with a water-soluble ketone solvent according to a conventional method.
  • the water-soluble ketone solvent used in this case include acetone and / or methyl ethyl ketone, but aceton is preferable.
  • acetone When acetone is used as the extraction solvent, it is usually about 10 to 30 mL per lg of dried product. If the amount of solvent used is less than 10 mL, the extraction process cannot be performed sufficiently, and the purity and recovery rate of the plasmalogen-type glycepore phospholipid in the insoluble part may be reduced. Meanwhile, over 30 mL Therefore, the effect of improving the purity and recovery rate of plasmalogen-type glycerophospholipid is hardly exhibited for the amount.
  • the preferable amount of the solvent used is 15 to 25 mL per 1 g of the dried processed product.
  • the extraction solution can be separated into a soluble part and an insoluble part (crude plasmalogen-type darice cellophospholipid) mainly composed of plasmalogen-type glycepore phospholipid by subjecting it to a centrifugal separation treatment.
  • the amount of plasmalogen-type glyceport phospholipid in the insoluble part is usually 40% by mass or more.
  • plasmalogen-type glyceport phospholipid can be produced with high purity and high yield from the total fat of poultry fillet, preferably chicken fillet, by simple means. .
  • 0.1 to 3 mass of crude plasma mouth-type glyce mouth phospholipid is usually obtained from the dry powder of chicken breast meat. / 0 can be obtained at a rate of about 0 .
  • the crude plasmalogen glycerophospholipid obtained by the method of the present invention mainly contains phosphatidylcholine (P C) and partly phosphatidylethanolamine (P E). About 30% by mass of the PC is a plasmalogen type, and PE contains about 65% by mass of a plasma single-gen type.
  • R 1 , R 2 long chain aliphatic group
  • glyce mouth phospholipid is a glycerol sn-1 (position 1) as shown in formula (II).
  • glycerol sn-1 position 1 as shown in formula (II).
  • the plasmalogen type has a butyl ether bond with an alkenyl group on sn-1 of glycerol as shown in formula (III).
  • X is an aminomino group, it is phosphatidylethanolamine, and when X is a trimethylaminoethyl group, it is phosphatidylcholine.
  • the plasmalogen glycerophospholipid is attracting attention as an antioxidant phospholipid because of its high radical sensitivity of vinyl ether bond, and is known to contribute to the oxidative stability of phospholipid membranes containing cholesterol. .
  • plasmalogen-type glyceport phospholipids are not only involved in the antioxidant properties of cell membranes and lipoproteins, but also have an important role in the cell signaling system.
  • Such plasmalogen-type glyceport phospholipids are expected to have the effect of preventing brain neuronal cell death in dementia and the onset prevention effect of atherosclerosis.
  • the present invention is also characterized by being obtained using the method of the present invention described above.
  • a plasmalogen-type glyceport phospholipid is also provided.
  • Freshly degassed and chilled chilled meat harvested from organic chicken laying hens (manufactured by Agricultural Union Enchikin (Chiran-cho, Minamikyushu-shi, Kagoshima)) (hereinafter sometimes referred to as "organic meat") )
  • organic meat a commercial minced device installed in an air-cooled chamber while minimizing air exposure during the process
  • 1 mm of minced with a size of several millimeters while maintaining the internal temperature at 1 oC or less 95 mass
  • Take the mince obtained in% yield in a high-paria film wrapping material immediately deaerate and store in a refrigerator.
  • the refrigerated mince was subjected to the following component analysis.
  • composition ratio and the content are mass%.
  • the characteristics of the fillet phospholipids in the waste chickens of organic farming breeding eggs are as follows.
  • PL-PC is the next higher function type, followed by P L_P E is large, but SM is extremely small.
  • Higher-order function type refers to a function that is directly involved in life homeostasis; for example, a function that inhibits apoptosis of cranial neurons or a function related to myocardial homeostasis.
  • the total PC is actually less than 70%.
  • total PE is less than 20%, of which 60% is P L-PE, in contrast to P L-PC in total PC, which is just over 20%. It is also noteworthy that the SM content is extremely low at 2% by mass, even compared to the skin described later.
  • composition ratio and the content are mass%.
  • the characteristic feature of the henrye phospholipids is that, first of all, it accounts for more than 80% of the total lipids with a content of only 1% by mass. Furthermore, almost 70% of the total PC is overwhelmingly large. Reflecting this, the higher-order function type has a high P L_PC of 30% by mass or more, but the SM is extremely low. Next to this, total PE is slightly over 17% by mass, of which, over 75% by mass is PL-PE, and in contrast to that PL-PC in total PC is over 45% by mass. It is. It is also noted that the SM content is extremely low at 3.2% by mass even compared to the epidermis described later.
  • composition of the phospholipid by HP LC / ELSD analysis was as follows: p1PC (21.4%), p1PE (13.4%), PC (50.3%), PE (4.8 %), SM (1.3%), the composition ratio of p1 type total is
  • composition ratio and content rate are mass%.
  • the deoiled minced skin prepared in Example 3 to be described later is 1.
  • composition ratio and the content are mass%.
  • the total lipid content jumps to at least about three times this, so the content of phospholipids decreases evenly by a fraction.
  • Freshly evacuated packaged chilled meat (produced by the Agricultural Union Act, artificial nuchikin) taken from waste eggs from egg-laying hens, preferably 1.2) described in mince 3 550 g, protein-treated natural preparation KO— X (Prepared by Osamu Kukino (Ichiki Kushikino Nashina 1126-1)) Dissolve 50 g in 2 50 ml of cold water, mix with refrigerated mince, and quickly with a food processor of a commercial home appliance. Then, 34.3 g of seasonings and spices were added and mixed well to obtain 6500 g of seasoned fillet minced meat (yield 95% by mass). This was deaerated and sealed and left in the refrigerator for several hours.
  • Example 1 of waste chicken fillet 3. Extraction of 400 g of freeze-dried powder using the method described above using 100 mL of ethanol as an extraction solvent, followed by extraction The effluent was dried by a rotary evaporator to obtain 12 g of total lipids. Then, the dried total lipids, per the lg, 2 0111] ⁇ 1 1 over hexane / Aseton (volume ratio 1Z 1) mixed solvent was added and 1 hour extraction process under ice cooling. Thereafter, the extraction solution was centrifuged at 100 G for 10 minutes to separate the soluble portion and the precipitate (insoluble portion) of the supernatant.
  • Example 1 1. 3) Concentrated and separated in the same manner as in Example 2 1. using 2 g of the total lipid obtained in (1) to obtain a concentrated phospholipid fraction of 1.4 g (yield 7 0%) was prepared. As a result of this HP L C_ ELSD analysis, [pi PC (70%) + 1 PE (30%)] 0.5 9 g (yield 4 2%) and [PC (9 4%) + PE ( 6%)] 0.69 g (yield 49.5%). 2) Female laying hens
  • Example 1 1. 3) Concentrated and separated in the same manner as in Example 2 1. using 2 g of the total lipid obtained in (2). Rate 63.7%) was prepared. As a result of this HPLC / ELSD analysis, [pl PC (60%) + p1PE (4 0%)] 0.45 g (yield 35.3%) and [PC (9 0%) + It was found to be PE (1 0%)] 0.71 g (yield 55.7%).
  • Fresh epidermis collected from waste chickens of egg-collecting hens was minced 8 mm under low temperature using the above-mentioned apparatus to obtain 4700 g (yield 94% by mass) of chicken skin mince. This was vacuum-packed with a high barrier film wrapping material and stored refrigerated. 300 g of this chicken skin minced is heated and deoiled minimally invasively at 105 ° C for 15 minutes with a low-oxygen hybrid steam heating device (made by Taiyoichi Seisakusho Co., Ltd. (Hito-Shimizugawa); hi-L0HS device). Thus, deoiled chicken skin 8 mm mince 14 45 g (yield 48 mass%) was obtained, vacuum-packed with a high barrier film packaging material, and stored refrigerated.
  • Refrigerated seasoned minced meat minced 45 5 g with chilled deoiled chicken skin minced 50 g After mixing, fryer with meatball molding device (1700 ° CZ for 3 minutes) To give about 30 g of meatballs 4550 g (yield 90 mass%) in a half-fried state. This half-fried meatball is heated at the above-mentioned hi-L0HS 1 1 5 ° C for 5.5 minutes, then left for 5 minutes and left to heat (Fig. 4). 3% by mass) was obtained. This was allowed to cool at room temperature, and then stored in a deaerated package frozen.
  • the frozen cooked chicken meat poles 10 pieces 2 95 5 g were thawed and heated in a microwave oven, and 2 9 2 g (yield 99% by mass) of hot chicken meat tops were obtained without dripping. .
  • the hot chicken meat pole obtained above was subjected to a two-choice sensory test with 12 adult men and women. As shown in Table 2, a high score was obtained. There were many impressions that the fried food was not oily and refreshed, and the texture was soft and juicy, and the taste and aroma of chicken were delicious.
  • composition ratio and the content are mass%.
  • Oral phospholipids can be produced with high yield by simple operations.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Fodder In General (AREA)

Abstract

Disclosed is a method for producing a phospholipid-containing functional material or a high-purity plasmalogen-type glycerophospholipid from a poultry breast meat by a simple manipulation and in high yield. Specifically disclosed are: a method for producing a phospholipid-containing functional material by transforming the shape of a poultry breast meat by at least one process selected from the following processes (a) to (c): (a) a process of mincing the poultry breast meat in a low-temperature and low-oxygen atmosphere; (b) a process of pasting the poultry breast meat together with an emulsifying/dispersing agent at a low temperature; and (c) a process of powderizing the poultry breast meat by drying at a low temperature; and a method for producing a plasmalogen-type glycerophospholipid, which comprises the following steps (A) to (C): (A) extracting the entire fat material from a powder of a poultry breast meat and drying the extracted fat material; (B) extracting the dried entire fat material with a solvent to separate into an insoluble fraction and a soluble fraction; and (C) extracting the soluble fraction with a solvent to separate and collect the insoluble fraction.

Description

明細書  Specification
リン脂質含有機能性素材の製造方法およびプラズマローゲン型グリセ口 リン脂質の製造方法 技術分野  Method for producing phospholipid-containing functional material and plasmalogen type glyce mouth Method for producing phospholipid Technical Field
本発明は、 家禽、 特にニヮト リのムネ肉から、 機能性食品素材、 医薬品 素材、 化粧品素材などとして有用なリン脂質含有機能性素材とプラズマ口 一ゲン型グリセ口リン脂質を、 簡単な操作で収率よく製造する方法、 並び にプラズマローゲン型グリセ口リン脂質に関するものである。 背景技術  The present invention provides a simple operation of a phospholipid-containing functional material useful as a functional food material, a pharmaceutical material, a cosmetic material, etc. The present invention relates to a method for producing with good yield, and also relates to a plasmalogen type glyceport phospholipid. Background art
脂質とは、 分子中に長鎖脂肪酸または類似の炭化水素鎖をもち、 生体内 に存在するか、 生物に由来する物質を指す。 この脂質は、 単純脂質と複合 脂質に分類することができる。 単純脂質は、 C、 Hおよび Oより構成され 、 一般にアセトンに可溶で、 単純脂質のトリァシルグリセロールは動物体 では、 脂肪組織にエネルギーの貯蔵体として存在する。 一方、 複合脂質は 、 リン酸の Pや塩基の Nなどを含む脂質群である。 したがって、 複合脂質 は、 疎水性部分 (脂肪酸部分) と親水性部分 (リン酸や塩基の部分) から なり、 両親媒性を示し、 一般的には、 前記単純脂質がアセ トンに可溶であ るのに対し、 複合脂質はアセトンに不溶である。 このような複合脂質は生 体膜の構成成分となっている。  Lipid refers to a substance that has a long-chain fatty acid or a similar hydrocarbon chain in a molecule and exists in a living body or is derived from a living organism. This lipid can be classified into simple lipids and complex lipids. Simple lipids are composed of C, H, and O, and are generally soluble in acetone. The simple lipid triacylglycerol exists in an animal body as a reservoir of energy in adipose tissue. On the other hand, complex lipids are a group of lipids including phosphoric acid P and base N. Therefore, complex lipids consist of a hydrophobic part (fatty acid part) and a hydrophilic part (phosphoric acid or base part), exhibiting amphipathic properties. Generally, the simple lipid is soluble in acetone. In contrast, complex lipids are insoluble in acetone. Such complex lipids are constituents of biological membranes.
前記複合脂質は、 (1 ) グリセ口リ ン脂質 [ホスファチジルコリ ン (別 名レシチン) 、 ホスファチジルエタノールァ ミ ンなどが属する。 ] 、 ( 2 ) スフィンゴリ ン脂質 (スフィンゴミエリ ン、 セラミ ドシリァチンな どが属する。 ) 、 ( 3 ) スフイ ンゴ糖脂質 (セレブ口シド、 スルファチ TJP2008/060120 ド、 ガンダリオシドなどが属する。 ) 、 および (4) グロセロ糖脂質 (微 生物や高等植物に存在するジァシルグリセロールに種々の糠が結合したも のなどがある。 ) に大別することができる。 なお、 前記 (2) スフイ ンゴ リ ン脂質および ( 3) のスフイ ンゴ糖脂質を総称してスフイ ンゴ脂質と呼 ばれる。 Examples of the complex lipid include (1) glyceline phospholipids [phosphatidylcholine (also known as lecithin), phosphatidylethanolamine, and the like. ], (2) Sphingolin lipids (sphingomyelin, ceramide dosylatin, etc.), (3) Glycosphingolipids (celebral mouthsides, sulfatides) TJP2008 / 060120 and Gandarioside belong. ), And (4) Groseroglycolipids (including those in which various cocoons are bound to diacylglycerol present in microorganisms and higher plants). The (2) sphingolipid lipid and the (3) sphingoglycolipid are collectively referred to as sphingolipids.
前記グリセ口リン脂質は、 ダリセロリン酸を骨格にもつリン脂質の総称 で、 ホスファチジルコ リ ン (レシチン) 、 ホスファチジルエタノーノレアミ ン、 ジホスフイチジルグリセロールなどがある。 このグリセ口リン脂質は 、 非極性部分が脂肪酸のエステルであるものが多いがビュルエーテル結合 をもつプラズマローゲン型のものもある。  The glyceport phospholipid is a general term for phospholipids having daricerophosphate as a skeleton, and includes phosphatidylcholine (lecithin), phosphatidylethanolanolin, diphosphitidylglycerol, and the like. Of these glyceport phospholipids, the nonpolar part is often an ester of a fatty acid, but there is also a plasmalogen type having a butyl ether bond.
このグリセ口リン脂質は、 生体膜の構成成分として重要であるが、 中で もプラズマローゲン型のグリセロリン脂質は、 ビニルエーテル結合のラジ カル感受性が高いため、 抗酸化性を有するリン脂質として、 近年注目され ている。 最近、 プラズマローゲン型グリセ口リン脂質が、 細胞膜の抗酸化 性分である α— トコフエロール (ビタミン E) とは異なった機構により、 コレステロールを含むリン脂質膜の酸化安定性に寄与していることが報告 されており (例えば、 「 J . L i p i d R e s . 」 、 第 44卷、 第 1 6 4〜 1 7 1頁 (2 00 3'年) 参照。 ) 、 またプラズマローゲン型ダリセロ リン脂質は、 細胞膜ゃリポタンパク質の抗酸化性に関与するだけでなく、 細胞の情報伝達システムに重要な役割を有することが指摘されている (例 えば、 「 J . Mo 1. N e u r o s c i . 」 、 第 1 6卷、 2 6 3〜 2 7 2 頁 ; d i s c u s s i o n 2 7 9〜 2 84頁 (2 0 0 1年) 参照) 。  This glyceport phospholipid is important as a component of biological membranes. Among them, plasmalogen-type glycerophospholipid has been recently attracting attention as an antioxidant phospholipid because it is highly sensitive to vinyl ether bonds. It has been. Recently, plasmalogen-type glyceport phospholipids have contributed to the oxidative stability of phospholipid membranes containing cholesterol by a mechanism different from that of α-tocopherol (vitamin E), an antioxidant component of cell membranes. (See, for example, “J. Lipid Res.”, Pp. 44, pp. 164-171 (2000 3 ′).) Also, the plasmalogen-type Darissello phospholipid is It has been pointed out that cell membranes are not only involved in the antioxidant properties of lipoproteins, but also have an important role in the cell signaling system (for example, “J. Mo 1. N eurosci.”, No. 16卷, pp. 2 63 3 to 2 7; see discussion 2 7 9 to 2 84 (2 0 0 1)).
このようなプラズマローゲン型グリセ口リン脂質は、 痴呆症における脳 の神経細胞死を防止する作用が期待されているが、 安全で大量に入手可能 な供給源は見当たらないのが実状である。 ところで、 食品、 動物組織などの総脂質から比較的多量のスフイ ンゴミ エリンを製造するためには、 ケィ酸などを使用したカラムクロマトグラフ ィ一で段階的に溶出して製造するか、 あるいは、 溶媒分画法で段階的に分 画して製造されている。 いずれも、 複雑な手順が必要である。 溶媒分画法 では総脂質にアセ トンを加えて複合脂質 (リ ン脂質) を沈殿させ (不溶部 ) 、 その不溶部をエーテルで洗ってグリセ口リン脂質を除いたものを粗ス フィ ンゴ脂質画分とする方法が一般的である。 この画分にはスフィンゴミ ェリンだけでなくセレブロシドなどのスフィンゴ糖脂質も含まれる。 Such plasmalogen-type glyceport phospholipids are expected to prevent brain neuronal cell death in dementia, but in reality there are no sources that are safe and available in large quantities. By the way, in order to produce a relatively large amount of sphingomyelin from total lipids of foods, animal tissues, etc., it can be produced by elution stepwise in a column chromatography using a key acid or the like, or a solvent Manufactured by fractionation using a fractionation method. Both require complex procedures. In the solvent fractionation method, acetone is added to total lipids to precipitate complex lipids (phospholipids) (insoluble part), and the insoluble part is washed with ether to remove the glyceport phospholipids. A method of fractionation is common. This fraction contains not only sphingomyelin but also glycosphingolipids such as cerebroside.
鶏皮のリン脂質には、 ヒ ト型スフィンゴミエリンおよびプラズマローゲ ン型ダリセロリン資質が多く含まれていることが知られている。  It is known that chicken skin phospholipids are rich in human sphingomyelin and plasmalogen-type dariceroline qualities.
鶏皮は、 従来の原料源に比べ、 ヒ ト型スフインゴミエリンの原料として その有用性が高いが、 皮下脂肪が極めて多く、 場合によっては 7 0質量% を超え、 この除去が煩雑を極めるという問題がある。 又、 鶏皮にはヒ ト型 スフインゴミエリンと同レベルのプラズマローゲン型グリセロリン脂質が 含まれ、 そのホスファチジルコリン (レシチン) とホスファチジノレエタノ ールァミンの割合は、 後者が顕著に高いのが特徴である。  Chicken skin is more useful as a raw material for human sphingomyelin compared to conventional raw material sources, but it contains a large amount of subcutaneous fat, sometimes exceeding 70% by mass, and this removal is extremely complicated. There's a problem. Chicken skin contains plasmalogen-type glycerophospholipid at the same level as human sphingomyelin, and the ratio of phosphatidylcholine (lecithin) and phosphatidinorethanolamine is significantly higher in the latter. is there.
本発明者らは、 鶏皮を凌ぐ原料の開発に鋭意取り組み、 鶏肉、 特にムネ 肉中に中性脂質含量が鶏皮に比べ 3 0〜7 0分の 1 レベルと極小で、 ヒ ト 型スフィンゴミエリンとプラズマローゲン型グリセ口リン脂質合計の含有 量が数倍の著量で、 然も、 プラズマローゲン型グリセ口リン脂質とヒ ト型 スフインゴミエリ ンの割合が、 前者が 8 5質量%強で、 更に、 プラズマ口 一ゲン型ダリセロリン脂質の構成比が、 成鶏では 5 0〜7 5質量%がホス ファチジルコリン、 若鶏では逆に 6割程度がホスファチジルエタノールァ ミンであり、 成鶏中のプラズマローゲン型ホスファチジルコリン含有量は 鶏皮の 3 0倍以上、 若鶏中のプラズマローゲン型ホスファチジルエタノー ルァミンは鶏皮の 2倍弱という、 プラズマローゲン型グリセ口リン脂質 ( 2種混合) 、 プラズマローゲン型ホスファチジルコリン単体、 及びプラズ マローゲン型ホスファチジルエタノールァミン単体、 各々の抽出原料とし て、 従来その例を見ない費用対効果に優れた家禽肉のムネ肉を見出すこと に成功した。 The present inventors have eagerly developed a raw material that surpasses chicken skin, and the neutral lipid content in chicken meat, especially rice meat, is 30 to 70 times smaller than chicken skin, and it is a human sphingo. The total content of myelin and plasmalogen-type glyceport phospholipids is several times greater. However, the ratio of plasmalogen-type glyceguchi phospholipids to human sphingomyelin is more than 85% by mass, In addition, the composition ratio of plasma mouth type darisserophospholipid is 50-75% by mass in adult chickens, phosphatidylcholine in young chickens, and phosphatidylethanolamine in young chickens. Plasmalogen-type phosphatidylcholine content is more than 30 times that of chicken skin, plasmalogen-type phosphatidylethanol in young chickens As a raw material for extraction of plasmalogen-type glyce mouth phospholipid (mixed in two kinds), plasmalogen-type phosphatidylcholine alone, and plasmalogen-type phosphatidylethanolamine alone, which is about twice as low as chicken skin, conventional examples We succeeded in finding a poultry fillet that was not cost-effective.
成鶏ムネ肉は、 総脂質が 1質量。/。と僅少で、 その 8割がリン脂質 (中 性脂質は 0 . 2質量%と極小) であって、 その内プラズマローゲン型グリ セロリン脂質は 4 5質量% (その内の 7割がプラズマローゲン型ホスファ チジルコリ ン) で、 生ムネ肉中の含有率は 0 . 3 6質量% (ヒ ト型スフィ ンゴミエリンは僅かに 0 . 0 3質量0 /0 ) と高く、 これを主材として加工す るだけで付加価値の高い機能性食品を調製出来る。 因みに、 家禽ムネ肉は 、 もも肉と並んで採肉率が高いが、 硬くてパサ付く食感とジユーシー感に 欠ける食味性のため、 ヘルシーにも拘わらず長い間現在まで食肉としては 低利用の扱いを受けている。 年間間引かれる採卵廃鶏 1億羽、 2 0万トン から採肉されるムネ肉は 1 5千トンに上り、 国産畜肉として大事に利用す ることが強く求められる。 発明の開示 Adult fillet has 1 mass of total fat. /. 80% of them are phospholipids (neutral lipids are as small as 0.2% by mass), of which 45% by mass is plasmalogen-type glycerophospholipid (70% of which is plasmalogen-type) in phospha Chijirukori down) content in the raw breast 0s. 3 6 wt% (human type Sufi Ngomierin is slightly 0.0 3 mass 0/0), which is high, Rudake be processed as a main material Can be used to prepare functional foods with high added value. By the way, poultry fillet, along with thighs, has a high rate of meat collection, but because it is hard and crunchy and lacks juicy taste, it has been treated as low-use meat for a long time despite being healthy. Is receiving. The annual meat culled from 100 million hens and 200,000 tons of minced meat is 15,000 tons, and it is strongly required to use them as domestic livestock. Disclosure of the invention
発明が解決しようとする課題 Problems to be solved by the invention
本発明は、 このような事情のもとで、 家禽、 特にニヮ トリのムネ肉から 、 プラズマローゲン型グリセ口リン脂質を多く含有する機能性素材を製造 する方法、 及び家禽ムネ肉粉末、 好ましくは上記機能性素材から純度の高 いプラズマローゲン型グリセ口リン脂質を、 簡単な操作で収率よく製造す る方法を提供することを目的とするものである。 課題を解決するための手段 Under such circumstances, the present invention is a method for producing a functional material containing a large amount of plasmalogen-type glyce mouth phospholipid from poultry, particularly chicken fillet, and poultry fillet powder, An object of the present invention is to provide a method for producing a high-purity plasmalogen-type glyceport phospholipid from the above functional material with a simple operation and in a high yield. Means for solving the problem
本発明者らは、 前記目的を達成するために鋭意研究を重ねた結果、 家禽 、 特に鶏のムネ肉に特定の工程を施すことにより、 プラズマローゲン型グ リセロリン脂質を多く含有する機能性素材が効率よく得られること、 そし て家禽ムネ肉粉末に特定の工程を施すことにより、 純度の高いプラズマ口 一ゲン型グリセ口リン脂質が効率よく得られることを見出し、 この知見に 基づいて本発明を完成するに至った。  As a result of intensive research to achieve the above object, the present inventors have obtained a functional material containing a large amount of plasmalogen-type glycerophospholipid by applying a specific process to poultry, particularly chicken fillet. It has been found that high-purity plasma-single-type glycepore phospholipids can be obtained efficiently by applying a specific process to poultry fillet powder, and based on this finding, the present invention is It came to be completed.
すなわち、 本発明は、  That is, the present invention
( 1 ) 家禽ムネ肉を、 ( a ) 低温 ·低酸素雰囲気下でのミンチ化工程、 (b ) 乳化分散剤を用いた低温下でのペース ト化工程おょぴ ( c ) 低温乾 燥での粉末化工程の中から選ばれる少なく とも一つの工程によって形状変 換することにより、 リ ン脂質含有機能性素材を製造する方法であって、 プ ラズマローゲン型グリセロリン脂質とスフインゴミエリンとの合計量中の 前者の含有割合が 8 5質量%以上であり、 かつ総脂質中の全リ ン脂質の含 有割合が 4 0質量%以上であるリン脂質含有機能性素材を得ることを特徴 とする、 リ ン脂質含有機能性素材の製造方法、  (1) Poultry fillet (a) Mince process at low temperature and low oxygen atmosphere, (b) Paste process at low temperature using emulsifying dispersant (c) Low temperature drying A method for producing a functional material containing a phospholipid by transforming its shape by at least one process selected from the powdering processes of the above, comprising the sum of plasmalogen-type glycerophospholipid and sphingomyelin A phospholipid-containing functional material in which the content of the former in the amount is 85% by mass or more and the content of all phospholipids in the total lipid is 40% by mass or more is obtained. , Manufacturing method of functional material containing phospholipid,
( 2) 家禽ムネ肉が皮剥ぎムネ肉である上記 ( 1 ) 項に記載の方法、 (2) The method according to (1) above, wherein the poultry fillet is a peeled fillet,
( 3 ) 家禽が成鶏 (以下、 廃鶏ということがある) であり、 かつプラズ マローゲン型グリセロリン脂質中のホスファチジルコリンとホスファチジ ルエタノールァミンの構成比率において、 前者が 4 0質量%以上である、 上記 ( 1 ) または (2) 項に記載の方法、 (3) The poultry are adult chickens (hereinafter sometimes referred to as abandoned chickens), and the former is 40% by mass or more in the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glycerophospholipid. The method described in (1) or (2) above,
(4) 家禽がブロイラー種鶏雌雄の成鶏であり、 かつプラズマローゲン型 グリセロリン脂質中のホスファチジノレコリンとホスファチジルエタノ一ノレ ァミンの構成比率において、 前者が 5 0質量%以上である、 上記 ( 1 ) ま たは (2) 項に記載の方法、 (5) 家禽がプロイラーであり、 かつプラズマローゲン型グリセ口リン 脂質中のホスファチジルコリンとホスファチジルエタノールァミンの構成 比率において、 後者が 50質量%以上である、 上記 ( 1) または (2) 項 に記載の方法、 (4) The poultry are adult broiler chickens and males, and the composition ratio of phosphatidinorecholine and phosphatidylethanolamine in plasmalogen-type glycerophospholipid is 50% by mass or more, (1) or the method described in (2), (5) The poultry is a pleuler, and the latter is 50% by mass or more in the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glycepore phospholipid, as described in (1) or (2) above the method of,
(6) (A) 家禽ムネ肉粉末から総脂質を抽出し、 乾燥処理する工程、 (B) 前記 (A) 工程で得られた乾燥総脂質を、 脂肪族炭化水素系溶剤と 水溶性ケトン系溶剤との混合溶剤で抽出処理し、 不溶部と、 プラズマロー ゲン型グリセ口リン脂質を主体とする可溶部とに分離する工程、 (C) 前 記 (B) 工程で得られた可溶部を乾燥処理後、 水溶性ケトン系溶剤で抽出 処理し、 プラズマローゲン型グリセ口リン脂質を主体とする不溶部を分離 回収する工程、 を含むことを特徴とするプラズマローゲン型グリセ口リン 脂質の製造方法、  (6) (A) Extracting the total lipid from the poultry fillet powder and drying it. (B) Drying the total lipid obtained in the step (A), using an aliphatic hydrocarbon solvent and a water-soluble ketone system. Extraction with a solvent mixture with a solvent, and separation into an insoluble part and a soluble part mainly composed of plasmalogen-type glyceport phospholipids (C) A portion of the plasmalogen-type glyceport phospholipid, characterized by comprising: a step of subjecting the product to drying treatment, followed by extraction with a water-soluble ketone solvent, and separating and recovering insoluble portions mainly composed of plasmalogen-type glyceport phospholipid. Production method,
( 7 ) (B) 工程における混合溶剤が、 n—へキサンとアセトンとを容 量比 4 : 6〜6 : 4の割合で含み、 かつその使用量が、 乾燥総脂質 1 g当 たり、 1 0〜 3 0mLである上記 (6) 項に記載の方法、  (7) The mixed solvent in step (B) contains n-hexane and acetone in a volume ratio of 4: 6 to 6: 4, and the amount used is 1 per 1 g of dry total lipid. The method according to item (6), which is 0 to 30 mL,
(8) (C) 工程における水溶性ケトン系溶剤がアセトンであり、 その 使用量が、 (B) 工程で得られた可溶部の乾燥処理物 1 g当たり、 1 0〜 3 0 mLである上記 (6) または (7) 項に記載の方法、  (8) The water-soluble ketone solvent in step (C) is acetone, and the amount used is 10 to 30 mL per 1 g of the dried processed product of the soluble part obtained in step (B). The method described in (6) or (7) above,
(9) 上記 (6) 〜 (8) 項のいずれか 1項に記載の方法を用いて得ら れたことを特徴とするプラズマローゲン型グリセ口リン脂質、  (9) A plasmalogen-type glyceport phospholipid characterized by being obtained using the method according to any one of (6) to (8) above,
を提供するものである。 発明の効果 Is to provide. The invention's effect
本発明によれば、 家禽、 特にニヮ トリのムネ肉から、 機能性食品素材、 医薬品素材、 化粧品素材などとして有用な、 プラズマローゲン型グリセ口 リン脂質とスフィンゴミエリンの構成比で前者が 8割以上で、 総脂質中の 全リン脂質の割合が 4割以上占めるリン脂質含有機能性素材を製造する方 法、 及び家畜ムネ肉粉末あるいは当該リン脂質含有機能性素材からプラズ マローゲン型グリセロリン脂質、 プラズマローゲン型ホスファチジノレコリ ン単体、 及びプラズマローゲン型ホスファチジルエタノールァミン単体を 、 簡単な操作で収率よく製造する方法、 並びにこの方法で得られたプラズ マローゲン型グリセロリン脂質、 プラズマローゲン型ホスファチジルコリ ン単体、 及びプラズマローゲン型ホスファチジノレエタノールァミ ン単体を 提供することができる。 According to the present invention, a plasmalogen-type glyce mouth which is useful as a functional food material, a pharmaceutical material, a cosmetic material, etc. from poultry, particularly chicken breast meat. A method for producing a phospholipid-containing functional material in which the former is 80% or more of the total phospholipid and sphingomyelin, and the proportion of total phospholipids in the total lipid is 40% or more. A method for producing a plasmalogen-type glycerophospholipid, a plasmalogen-type phosphatidinorecollin simple substance, and a plasmalogen-type phosphatidylethanolamine simple substance from a lipid-containing functional material with a simple operation and a high yield. Plasmalogen-type glycerophospholipid, plasmalogen-type phosphatidylcholine simple substance, and plasmalogen-type phosphatidinoleethanolamine simple substance can be provided.
本発明の家禽ムネ肉の形状変換技術、 乳化分散天然製剤によるペース ト 化技術は、 加熱処理で硬くならず、 冷凍 ·解凍処理でも副生ドリ ップがな くジユーシー感を保つ副次的機能を有する故、 当該ムネ肉ペース トはムネ 肉の高付加価値化食材として極めて有用であり、 本発明がムネ肉の高付加 価値化の端緒となって、 その消費が拡大される結果として人々の健康増進 に貢献するものと期待される。 図面の簡単な説明  The poultry fillet shape-changing technology of the present invention and the pasting technology using emulsified and dispersed natural preparations are secondary functions that do not harden by heat treatment and maintain a succulent feeling with no by-product dripping even during freezing and thawing treatment. Therefore, the rice paste is extremely useful as a high-value-added food material for rice meat, and the present invention is the beginning of high-value-added rice meat, resulting in an increase in consumption. It is expected to contribute to health promotion. Brief Description of Drawings
図 1 廃鶏ムネ肉から各操作で得られた物質の E L S D検出クロマトグ ラムである。  Fig. 1 ELS D detection chromatogram of substances obtained from waste chicken fillet by each operation.
図 2 有機農法育成採卵鶏 (地鶏) の廃鶏ムネ肉から各操作で得られた 物質の E L S D検出クロマトグラムである。  Fig. 2 ELSD detection chromatograms of substances obtained by each operation from waste chicken fillet of organic farming breeding hens (local chickens).
図 3 市販若鶏のムネ肉から各操作で得られた物質の E L S D検出クロ マトグラムである。  Fig. 3 ELSD detection chromatograms of substances obtained from each operation of commercially available young chicken breast meat.
図 4 半揚げ状態のミートボールの hi- L0HS 1 1 5 °C 5 . 5分間加熱 5分間余熱加熱の時間 · 温度チャートである。 P T/JP2008/060120 Fig. 4 Half-fried meatball hi-L0HS 1 15 ° C 5.5 minutes heating 5 minutes preheating heating time · temperature chart. PT / JP2008 / 060120
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
本発明のリン脂質含有機能性素材の製造方法は、 以下に示す (a) 工程 、 (b ) 工程および (c) 工程の中から選ばれる少なく とも一つの工程か ら構成されており、 プラズマローゲン型グリセ口リン脂質の製造方法は、 (A) 工程、 (B) 工程および (C) 工程から構成されている。 The method for producing a phospholipid-containing functional material of the present invention comprises at least one step selected from the following steps ( a ), (b) and (c): The production method of type glyceguchi phospholipid is composed of (A) step, (B) step and (C) step.
まず、 本発明のリン脂質含有機能性素材の製造方法について説明する。  First, the manufacturing method of the phospholipid containing functional material of this invention is demonstrated.
[ (a ) 工程]  [(a) Process]
この (a ) 工程は、 低温 ·低酸素雰囲気下でのミンチ化工程である。 当該 (a) 工程では、 家禽ムネ肉、 特に鶏ムネ肉、 皮付きの場合には先 ずスキナー処理で皮を剥いた後、 常法通りミンチ化するが、 その際に、 ム ネ肉の品温を低く、 好ましくは 5。C以下に冷却し、 ミンチ化サイズとミン チ化速度も細断部の局所的な発熱を回避することを優先させて設定するこ とが望ましい。 又、 ミンチ化後のミンチ肉と空気暴露を最少化させ、 更に 、 空気酸化と雑菌感染を抑制するため空気清浄化装置付きの、 室温を低く 、 好ましくは 1 5°C以下の準密閉空間内で当該処理とその密封包装を実施 することが好ましい。 得られたミンチは、 ハイバリアー性フィルムで真空 包装し、 冷蔵保存するのがよい。  This step (a) is a mincing step in a low temperature / low oxygen atmosphere. In the process (a), poultry fillet, especially chicken fillet, if it has a skin, it is first skinned with a skinner treatment and then minced as usual. Lower the temperature, preferably 5. It is desirable to set the minced size and minced rate with priority given to avoiding local heat generation at the shredded portion after cooling to C or lower. In addition, the minced meat and air exposure after mincing is minimized, and furthermore, with air purifiers to suppress air oxidation and bacterial infection, the room temperature is low, preferably in a semi-enclosed space of 15 ° C or less It is preferable to implement the treatment and its sealed packaging. The obtained mince should be vacuum-packed with a high barrier film and stored refrigerated.
[ (b) 工程]  [(b) Process]
この (b) 工程は、 乳化分散剤を用いた低温下でのペースト化工程であ る。  This step (b) is a pasting step at a low temperature using an emulsifying dispersant.
当該 (b) 工程では、 皮剥きムネ肉、 好ましくは、 上記 (a) 工程でミ ンチ化処理後真空包装冷蔵保管された肉に、 好ましくは非酵素系の蛋白質 食材用乳化分散化天然製剤を適量の水で溶解させた水溶液を添加して、 適 宜なカッターゃミキサー乃至はプロセッサーで均一に混合してペースト化 (ストレートタイプ) 後、 場合により適量の香辛料等を加えて分散混合さ せて調味済みタイプとし、 このペース トをハイパリァー性のフィルムで真 空包装後冷却して、 低温、 好ましくは冷蔵保管するのがよい。 長期間保管 には冷凍も可能である。 In the step (b), skinned fillet meat, preferably the meat that has been minced in the step (a) and vacuum-packed refrigerated and stored, preferably a non-enzymatic emulsion-dispersed natural preparation for protein foodstuffs. Add an aqueous solution dissolved in an appropriate amount of water, mix evenly with an appropriate cutter mixer or processor, and paste into a straight (straight type). It is recommended that the pasted type be prepared, and this paste be cooled with a high-parity film and then cooled and stored at a low temperature, preferably refrigerated. Refrigeration is possible for long-term storage.
[ ( c ) 工程]  [(c) Process]
この ( c ) 工程は、 低温乾燥での粉末化工程である。  This step (c) is a powdering step by low temperature drying.
当該 ( c ) 工程では、 皮剥きムネ肉、 好ましくは上記 (a ) 工程で真空 包装冷蔵保管されたミンチ肉、 場合によっては、 上記 (b ) 工程のス トレ 一トタイプペース トの何れかを常法に従い市販の凍結乾燥装置で適宜に低 侵襲的に乾燥し、 必要により低温粉砕により粉末化し、 この粉末をハイバ リァー性フィルム真空包装後遮光下で冷蔵保管するのがよい。  In the step (c), skinned meat, preferably minced meat that has been refrigerated and stored in vacuum in the step (a), or in some cases, any of the straight type pastes in the step (b) According to the method, it is better to dry it in a minimally invasive manner with a commercially available freeze-drying device, and if necessary, pulverize it by low-temperature pulverization, and store this powder refrigerated under light shielding after vacuum packaging of a hybrid film.
このよ うにして得られたリン脂質含有機能性素材においては、 プラズマ ローゲン型グリセ口リン脂質とスフィンゴミエリンとの合計量中の前者の 含有割合が 8 5質量%以上であり、 かつ総脂質中の全リン脂質の含有割合 が 4 0質量%以上である。  In the phospholipid-containing functional material obtained in this way, the content ratio of the former in the total amount of plasmalogen glyce mouth phospholipid and sphingomyelin is 85% by mass or more, and The total content of phospholipids is 40% by mass or more.
また、 家禽が成鶏である場合、 プラズマローゲン型グリセ口リン脂質中 のホスファチジルコリ ンとホスファチジルェタノールァミンの構成比率は 、 前者が 5 0質量%以上であり、 ブロイラー種鶏雌雄の成鶏である場合、 プラズマローゲン型グリセロ リ ン脂質中のホスファチジルコ リ ンとホスフ ァチジルエタノールアミンの構成比率は、 前者が 5 0質量。 /0以上であり、 ブロイラーである場合、 プラズマローゲン型グリセ口 リ ン脂質中のホスフ ァチジルコ リ ンとホスファチジルエタノールアミンの構成比率は、 後者が 5 0質量。 /0以上である。 In addition, when the poultry are adult chickens, the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glyce mouth phospholipid is 50% by mass or more of the former, and adult broiler chickens , The composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glycerin lipid is 50 masses in the former. / Is 0 or more, if a broiler, phosphine Achijiruko Li down and the component ratio of phosphatidyl ethanolamine plasmalogen type glycerin port Li down lipids, the latter 5 0 mass. / 0 or more.
次に、 本発明のプラズマローゲン型グリセ口リン脂質の製造方法につい て説明する。 [ ( A ) 工程] Next, a method for producing the plasmalogen glyceport phospholipid of the present invention will be described. [(A) Process]
この (A ) 工程は、 家禽ムネ肉粉末、 好ましくは鶏ムネ肉粉末から総脂 質を抽出し、 乾燥処理する工程である。 当該 (A ) 工程においては、 まず 、 家禽ムネ肉粉末を調製するが、 その場合、 ニヮ トリムネ肉をそのまま乾 燥 '粉末化してもよいし、 必要に応じ、 ミンチ化、 及びペース ト化処理し て、 乾燥 ·粉末化してもよい。 好ましくは、 前記 [ ( c ) 工程] で得られ るハイバリァー性フィルム真空包装後遮光下で冷蔵保管した粉末を使う。 次いで、 このようにして得られた家禽ムネ肉粉末から、 溶剤を用いて、 総脂質を抽出し、 乾燥処理して、 乾燥総脂質を得る。 総脂質の抽出に用い る溶剤としては、 食品衛生上安全であって、 かつ抽出効率のよいものが用 いられる。 このような溶剤としては、 特にエタノールが好適である。 この 抽出処理は、 常法に従って行うことができる。 ただし、 この抽出工程では エタノール可溶の非脂質成分も抽出される。  This step (A) is a step of extracting the total fat from the poultry fillet powder, preferably the chicken fillet powder, and drying it. In the step (A), first, poultry fillet powder is prepared. In that case, the rice trimet meat may be dried and pulverized as it is, and minced and pasted as necessary. Then, it may be dried and powdered. Preferably, a powder that is refrigerated and stored in a shaded state after vacuum packaging of the high barrier film obtained in [Step (c)] is used. Next, the total lipid is extracted from the poultry fillet powder thus obtained using a solvent and dried to obtain a dry total lipid. Solvents used for extraction of total lipids are those that are safe for food hygiene and have good extraction efficiency. As such a solvent, ethanol is particularly suitable. This extraction process can be performed according to a conventional method. However, ethanol-soluble non-lipid components are also extracted in this extraction process.
抽出液は、 常法に従い、 ロータリエバポレーターなどを用いて溶剤を留 去させることにより、 あるいは窒素ガスを導入することなどにより、 乾燥 総脂質が得られる。  According to a conventional method, the extract can be obtained by removing the solvent using a rotary evaporator or by introducing nitrogen gas.
[ ( B ) 工程]  [(B) Process]
この (B ) 工程は、 前記 (A ) 工程で得られた乾燥総脂質を、 脂肪族炭 化水素系溶剤と水溶性ケトン系溶剤との混合溶剤で抽出処理し、 不溶部と 、 可溶部とに分離する工程である。  In the step (B), the dry total lipid obtained in the step (A) is extracted with a mixed solvent of an aliphatic hydrocarbon solvent and a water-soluble ketone solvent, and an insoluble portion and a soluble portion are extracted. It is the process of separating into.
当該 (B ) 工程において、 乾燥総脂質の抽出処理に用いられる混合溶剤 の一成分である脂肪族系炭化水素系溶剤としては、 例えば n—ペンタン、 イソペンタン、 n一へキサン、 ィソへキサン、 n一へプタン、 イソへプタ ン、 シクロペンタン、 シクロへキサンなどが挙げられ、 これらは 1種を単 独で用いてもよく、 2種以上を混合して用いてもよいが、 これらの中で n 一へキサンが好適である。 In the step (B), examples of the aliphatic hydrocarbon solvent that is one component of the mixed solvent used for the extraction treatment of the dried total lipid include n-pentane, isopentane, n-hexane, isohexane, n Examples include monoheptane, isoheptane, cyclopentane, cyclohexane, etc., and these may be used alone or in combination of two or more. N Monohexane is preferred.
また、 前記混合溶剤の他方の成分である水溶性ケトン系溶剤としては、 例えばァセトンおよび/またはメチルェチルケトンなどを用いることがで きるが、 これらの中でアセトンが好適である。  Further, as the water-soluble ketone solvent which is the other component of the mixed solvent, for example, acetone and / or methyl ethyl ketone can be used, and among these, acetone is preferable.
混合溶剤として、 n—へキサンとアセトンとの混合物を用いる場合、 そ の割合は、 容量比で 4 : 6〜 6 : 4が好ましく、 4. 5 : 5. 5〜 5. 5 : 4. 5がより好ましい。  When a mixture of n-hexane and acetone is used as the mixed solvent, the ratio is preferably 4: 6 to 6: 4 in terms of volume ratio, and 4.5: 5.5 to 5.5: 4.5. Is more preferable.
また、 この混合溶剤の使用量は、 乾燥総脂質 l g当たり、 通常 1 0〜3 0 m L程度である。  The amount of the mixed solvent is usually about 10 to 30 mL per gram of dry total lipid.
[ (C) 工程]  [(C) Process]
この (C) 工程は、 前記 (B) 工程で得られた可溶部を乾燥処理後、 水溶性ケトン系溶剤で抽出処理し、 プラズマローゲン型グリセ口リン脂質 を主体とする不溶部 (以下、 粗プラズマローゲン型グリセ口リン脂質と称 することがある。 ) を分離回収する工程である。  In the step (C), the soluble part obtained in the step (B) is dried and then extracted with a water-soluble ketone solvent, and the insoluble part (hereinafter referred to as plasmalogen-type glyceport phospholipid) This is sometimes referred to as crude plasmalogen-type glycepore phospholipid.
当該 (C) 工程においては、 まず、 前記 (B) 工程で得られた可溶部を 、 常法に従って乾燥処理する。 例えばロータリエバポレーターを用いて、 前記可溶部中の混合溶剤を留去させる方法などを用いることができる。 次 いで、 このようにして得られた乾燥処理物を、 水溶性ケトン系溶剤により 、 常法に従って抽出処理する。 この際使用する水溶性ケトン系溶剤として は、 アセトンおよび/またはメチルェチルケトンを挙げることができるが 、 ァセトンが好適である。  In the step (C), first, the soluble part obtained in the step (B) is dried according to a conventional method. For example, a method of distilling off the mixed solvent in the soluble part using a rotary evaporator can be used. Next, the dried product obtained in this way is extracted with a water-soluble ketone solvent according to a conventional method. Examples of the water-soluble ketone solvent used in this case include acetone and / or methyl ethyl ketone, but aceton is preferable.
抽出溶剤としてアセトンを使用する場合、 乾燥処理物 l g当たり、 通常 1 0〜 3 0 mL程度である。 溶剤の使用量が 1 0 mL未満では、 抽出処理 を十分に行うことができず、 不溶部中のプラズマローゲン型グリセ口リン 脂質の純度低下や回収率の低下を招くおそれがある。 一方 3 0 mLを超え ると、 その量の割にはプラズマローゲン型グリセロリン脂質の純度や回収 率の向上効果が発揮されにくい。 溶剤の好ましい使用量は、 乾燥処理物 1 g当たり、 1 5〜2 5 m Lである。 When acetone is used as the extraction solvent, it is usually about 10 to 30 mL per lg of dried product. If the amount of solvent used is less than 10 mL, the extraction process cannot be performed sufficiently, and the purity and recovery rate of the plasmalogen-type glycepore phospholipid in the insoluble part may be reduced. Meanwhile, over 30 mL Therefore, the effect of improving the purity and recovery rate of plasmalogen-type glycerophospholipid is hardly exhibited for the amount. The preferable amount of the solvent used is 15 to 25 mL per 1 g of the dried processed product.
抽出処理液は、 遠心分離処理を施すことにより、 可溶部とプラズマロー ゲン型グリセ口リン脂質を主体とする不溶部 (粗プラズマローゲン型ダリ セロリン脂質) に分離することができる。 不溶部におけるプラズマローゲ ン型グリセ口リン脂質の量は、 通常 4 0質量%以上である。  The extraction solution can be separated into a soluble part and an insoluble part (crude plasmalogen-type darice cellophospholipid) mainly composed of plasmalogen-type glycepore phospholipid by subjecting it to a centrifugal separation treatment. The amount of plasmalogen-type glyceport phospholipid in the insoluble part is usually 40% by mass or more.
このような本発明の方法によれば、 家禽ムネ肉、 好ましくは鶏ムネ肉の 総脂質から、 簡単な手段によって、 プラズマローゲン型グリセ口リン脂質 を、 高い純度で収率よく製造することができる。  According to such a method of the present invention, plasmalogen-type glyceport phospholipid can be produced with high purity and high yield from the total fat of poultry fillet, preferably chicken fillet, by simple means. .
本発明の方法によれば、 鶏ムネ肉の乾燥粉末から、 通常、 粗プラズマ口 一ゲン型グリセ口リン脂質を 0 . 1〜 3質量。 /0程度の割合で得ることがで きる。 According to the method of the present invention, 0.1 to 3 mass of crude plasma mouth-type glyce mouth phospholipid is usually obtained from the dry powder of chicken breast meat. / 0 can be obtained at a rate of about 0 .
本発明の方法で得られる粗プラズマローゲン型グリセロリン脂質には、 主としてホスファチジルコリン (P C ) が含まれており、 一部ホスファチ ジルエタノールァミン (P E ) が含まれている。 前記 P Cは、 約 3 0質量 %がプラズマローゲン型であり、 また P Eには約 6 5質量%のプラズマ口 一ゲン型が含まれている。  The crude plasmalogen glycerophospholipid obtained by the method of the present invention mainly contains phosphatidylcholine (P C) and partly phosphatidylethanolamine (P E). About 30% by mass of the PC is a plasmalogen type, and PE contains about 65% by mass of a plasma single-gen type.
下記の式 (II) および式 (II I) に、 それぞれジァシル型グリセ口リン 脂質およびプラズマローゲン型グリセ口リン脂質の構造を示す。
Figure imgf000014_0001
The following formulas (II) and (II I) show the structures of diacyl glycated phospholipid and plasmalogen glycated phospholipid, respectively.
Figure imgf000014_0001
R1、 R2 =長鎖肪肪族基 R 1 , R 2 = long chain aliphatic group
X=—CH2CH2NH2、 一 CH2CH2N(CH3)3 通常のグリセ口リン脂質 (レシチン) は、 式 (II) で示されるようにグ リセロールの s n— 1 ( 1位) に脂肪酸ァシル基とのエステル結合をもつ 力 S、 プラズマローゲン型は、 式 (III) で示されるようにグリセロールの s n— 1にアルケニル基をもつビュルエーテル結合を有している。 X = —CH 2 CH 2 NH 2 , 1 CH 2 CH 2 N (CH 3 ) 3 Normal glyce mouth phospholipid (lecithin) is a glycerol sn-1 (position 1) as shown in formula (II). ) Has an ester bond with a fatty acid acyl group, and the plasmalogen type has a butyl ether bond with an alkenyl group on sn-1 of glycerol as shown in formula (III).
なお、 Xがァミノェチル基である場合、 ホスファチジルェタノールァミ ンであり、 Xがトリメチルァミノェチル基である場合、 ホスファチジルコ リ ンである。  When X is an aminomino group, it is phosphatidylethanolamine, and when X is a trimethylaminoethyl group, it is phosphatidylcholine.
前記プラズマローゲン型グリセロリン脂質は、 ビニルエーテル結合のラ ジカル感受性が高いため抗酸化性リン脂質として注目されており、 コレス テロールを含むリン脂質膜の酸化安定性に寄与していることが知られてい る。 またプラズマローゲン型グリセ口リン脂質は、 細胞膜ゃリポタンパク 質の抗酸化性に関与するだけでなく、 細胞の情報伝達システムに重要な役 割を有することが指摘されている。 このようなプラズマローゲン型グリセ 口リン脂質は、 痴呆症における脳の神経細胞死を防止する作用や、 ァテロ ーム性動脈硬化症の発症予防効果などが期待されている。  The plasmalogen glycerophospholipid is attracting attention as an antioxidant phospholipid because of its high radical sensitivity of vinyl ether bond, and is known to contribute to the oxidative stability of phospholipid membranes containing cholesterol. . In addition, it has been pointed out that plasmalogen-type glyceport phospholipids are not only involved in the antioxidant properties of cell membranes and lipoproteins, but also have an important role in the cell signaling system. Such plasmalogen-type glyceport phospholipids are expected to have the effect of preventing brain neuronal cell death in dementia and the onset prevention effect of atherosclerosis.
本発明はまた、 前述した本発明の方法を用いて得られたことを特徴とす るプラズマローゲン型グリセ口リン脂質をも提供する。 実施例 The present invention is also characterized by being obtained using the method of the present invention described above. A plasmalogen-type glyceport phospholipid is also provided. Example
次に、 本発明を実施例により、 さらに詳細に説明するが、 本発明は、 こ れらの例によってなんら限定されるものではない。  Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
実施例 1 Example 1
1. 高次機能性リン脂質含有機能性ミンチ  1. Functional mince containing higher-order functional phospholipids
1 ) 有機農法育成採卵鶏の廃鶏のムネ肉  1) Organic farming breeding egg collection chicken waste meat
有機農法育成採卵鶏の廃鶏から採肉された新鮮な脱気包装冷蔵ムネ肉 (農事組合法人ェヌチキン (鹿児島県南九州市知覧町) 製) (以下、 「有 機ムネ肉」 と言うことがある。 ) 1kgを、 工程中の空気暴露を最少化しな がら空冷室内に設置した市販ミンチ装置でその装置内温度を 1 o°c以下に 保持しながら数 mmサイズのミンチ処理を行い、 9 5質量%収率で得られた ミンチを高パリァ性フィルム包材に取り、 直ちに脱気包装して冷蔵保管す る。  Freshly degassed and chilled chilled meat harvested from organic chicken laying hens (manufactured by Agricultural Union Enchikin (Chiran-cho, Minamikyushu-shi, Kagoshima)) (hereinafter sometimes referred to as "organic meat") ) Using a commercial minced device installed in an air-cooled chamber while minimizing air exposure during the process, 1 mm of minced with a size of several millimeters while maintaining the internal temperature at 1 oC or less, 95 mass Take the mince obtained in% yield in a high-paria film wrapping material, immediately deaerate and store in a refrigerator.
該冷蔵ミンチを以下の成分分析に供した。  The refrigerated mince was subjected to the following component analysis.
常法により該ミンチ 1 0 gを Bligh & Dyer法で抽出した総脂質 2 0 6. 2m gをアセ トン 1 0m lで沈殿させて 9 9 m gの総リン脂質 (含有率 0 . 9 9質量%) を得た。 これを HP L Cで分析し、 蒸発光散乱法 (E L S D) でそのピーク面積比から構成リ ン脂質の構成比を計算した。 これを基 にリン脂質分子の含有率とその含有量を求めて結果を表 1に示した。 60120 表 1 10 mg of the total amount of phospholipid (content: 0.9 9 mass%) was prepared by precipitating 20 6.2 mg of total lipid extracted by Bligh &Dyer's method with 10 ml of aceton by 10 mg ) This was analyzed by HP LC, and the constituent ratio of the constituent phospholipids was calculated from the peak area ratio by evaporative light scattering (ELSD). Based on this, the content and content of phospholipid molecules were determined and the results are shown in Table 1. 60120 Table 1
Figure imgf000016_0001
Figure imgf000016_0001
(構成比、含有率は質量%である。)  (The composition ratio and the content are mass%.)
有機農法育成採卵鶏の廃鶏のムネ肉リン脂質の特徴は、 先ず、 含有率が The characteristics of the fillet phospholipids in the waste chickens of organic farming breeding eggs are as follows.
2. 1質量%しかない総脂質中に、 その 5割を占めていること、 その半分 以上が P Cで圧倒的に多く、 これを反映して高次機能型では P L— P Cが 、 次いで P L_P Eが多いが、 SMが極めて少ない。 なお、 高次機能型と は、 生命の恒常性 (ホメォスタシス) に直接的に関与する機能;例えば、 脳神経細胞のアポトーシスの抑制や、 心筋の恒常性に関与する機能を有す るものを指称する。 更に、 総 P Cは実に 7割弱に上る。 これに次いで総 P Eは 2割弱であるが、 その内、 6割が P L— P Eで、 総 P C中の P L— P Cが僅かに 2割強であることと対照的である。 SM含有量が、 後述する表 皮中と比較しても、 2質量%と極めて低いことも注目される。 2. 50% of the total lipid is only 1% by mass, and more than half of it is overwhelmingly PC. Reflecting this, PL-PC is the next higher function type, followed by P L_P E is large, but SM is extremely small. Higher-order function type refers to a function that is directly involved in life homeostasis; for example, a function that inhibits apoptosis of cranial neurons or a function related to myocardial homeostasis. . Furthermore, the total PC is actually less than 70%. Next to this, total PE is less than 20%, of which 60% is P L-PE, in contrast to P L-PC in total PC, which is just over 20%. It is also noteworthy that the SM content is extremely low at 2% by mass, even compared to the skin described later.
2) 採卵廃鶏のムネ肉  2) Egg waste chicken
1. 1 ) と同様に、 脂質分析を実施した。 その結果を纏めて表 2に示し た。 TJP2008/060120 表 2 1. Lipid analysis was performed as in 1). The results are summarized in Table 2. TJP2008 / 060120 Table 2
Figure imgf000017_0001
Figure imgf000017_0001
(構成比、含有率は質量%である。)  (The composition ratio and the content are mass%.)
採卵鶏の廃鶏のムネ肉リン脂質の特徴は、 先ず、 含有率が僅かに 1質量 %弱しかない総脂質中に、 その実に 8割以上を占めていることである。 更 に、 その 7割弱が総 P Cで圧倒的に多く、 これを反映して高次機能型では P L_ P Cが 3 0質量%以上と多いが、 SMが極めて少ない。 これに次い で総 P Eは 1 7質量%強であるが、 その内、 7 5質量%強が P L— P Eで 、 総 P C中の P L— P Cが 4 5質量%強であることと対照的である。 SM 含有量が、 後述する表皮中と比較しても、 3. 2質量%と極めて低いこと も注目される。  The characteristic feature of the henrye phospholipids is that, first of all, it accounts for more than 80% of the total lipids with a content of only 1% by mass. Furthermore, almost 70% of the total PC is overwhelmingly large. Reflecting this, the higher-order function type has a high P L_PC of 30% by mass or more, but the SM is extremely low. Next to this, total PE is slightly over 17% by mass, of which, over 75% by mass is PL-PE, and in contrast to that PL-PC in total PC is over 45% by mass. It is. It is also noted that the SM content is extremely low at 3.2% by mass even compared to the epidermis described later.
3) ブロイラー種鶏雌雄の成鶏  3) Adult broiler chickens
( 1 ) ブロイラー種鶏雄の成鶏  (1) Adult broiler chicken
チャンキー種 5羽 (平均質量 5. 9 k g ) から採肉された脱気包装冷蔵 の新鮮な皮剥きムネ肉 ( (農事組合法人) ェヌチキン製) 各々から 2 0 g のサンプルを採取し、 前記 1 ) と同様に総脂質平均 0. 2 g (平均収率 1 %) を抽出した。 各々の総脂質から平均 7 5質量%のリン脂質画分 0. 1 5 gを分離した。 該リ ン脂質の HP L C/E L S D分析による組成は、 p 1 P C (2 8. 7 %) , p 1 P E ( 1 1. 2%) , P C (4 3. 7 %) , P E ( 3. 2 %) , SM ( 5. 1 %) で、 p 1型合計の構成比は 3 9. 9 % (ムネ肉中の含有率 0. 2 8 %) を示した。 Degassed and chilled fresh peeled minced meat (from Agricultural Union) made from 5 chunky varieties (average mass 5.9 kg) Take 20 g samples from each In the same manner as in 1), an average total lipid of 0.2 g (average yield of 1%) was extracted. An average of 0.15 g of a phospholipid fraction of 75% by mass was separated from each total lipid. The composition of the phospholipid by HP LC / ELSD analysis is p 1 PC (2 8. 7%), p 1 PE (1 1.2%), PC (4 3.7%), PE (3 .2%), SM (5.1%), p 1 The composition ratio of the total mold was 39.9% (content ratio in fillet 0.28%).
(2) ブロイラー種鶏雌の成鶏  (2) Broiler breeder female adults
チャンキー種 5羽 (平均質量 3. 8 k g) から採肉された脱気包装冷蔵 の新鮮な皮剥きムネ肉 ( (農事組合法人) ェヌチキン製) 各々から 2 0 g のサンプルを採取し、 前記 1 ) と同様に総脂質平均 0. 4 7 g (平均収率 Degassed and chilled fresh peeled minced meat (from Agricultural Association) made from 5 chunky varieties (average mass 3.8 kg) Take 20 g samples from each 1) Similar to total lipid average 0.47 g (average yield)
2. 3 5 %) を抽出した。 各々の総脂質から平均 6 5質量%のリ ン脂質画 分 0. 3 gを分離した。 該リ ン脂質の HP L C/E L S D分析による組成 は、 p 1 P C ( 2 1. 4 % ) , p 1 P E ( 1 3. 4 % ) , P C ( 5 0. 3%) , P E (4. 8 %) , SM (1. 3 %) で、 p 1型合計の構成比は2. 35%) was extracted. An average of 0.3 g of phospholipid fraction of 65% by mass was separated from each total lipid. The composition of the phospholipid by HP LC / ELSD analysis was as follows: p1PC (21.4%), p1PE (13.4%), PC (50.3%), PE (4.8 %), SM (1.3%), the composition ratio of p1 type total is
3 5 % (ムネ肉中の含有率 0. 5 4%) を示した。 3 5% (content ratio in fillet 0.5 4%).
4) 若鶏のムネ肉 4) Young chicken fillet
市販のブロイラーを調達して 1. 1 ) と同様に、 脂質分析を実施した。 その結果を纏めて表 3に示した。 若鶏 (ブロイラー) のムネ肉リ ン脂質の 特徴は、 前 2例の成鶏の場合と同様に、 僅かに 1質量。/。強の総脂質に占め る割合が 2 / 3と多く、 総 P Cが 7割弱と最大, 次いで総 P Eが 2割強で ある。 高次機能型では、 SMが 2質量%と低く、 総 P Eの 7割弱が P L— P Eである点は成鶏と類似しているが、 総 P Cの組成が前 2例の成鶏の場 合と異なり、 P L— P Cの占める割合は 1 3質量%台と著減し、 その含有 率も 1 / 3 と低下している。 表 3 A commercial broiler was procured and lipid analysis was performed in the same manner as in 1.1). The results are summarized in Table 3. The characteristics of young chicken (broiler) fillet phospholipids are only 1 mass, similar to the previous two adult chickens. /. The ratio of strong total lipids is as high as 2/3, the total PC is a little less than 70%, and the total PE is more than 20%. The higher-functional, SM is as low as 2 wt%, nearly 70% of the total PE is PL-PE at a point similar to adult chickens, but the field of adult chickens in the composition of the total PC previous two cases Unlike the case, the proportion of PL-PC is markedly reduced to the 13% by mass range, and its content is also reduced to 1/3. Table 3
Figure imgf000019_0001
Figure imgf000019_0001
(構成比、含有率は質量%である。 )  (The composition ratio and content rate are mass%.)
5 ) 比較対照;採卵廃鶏表皮  5) Comparison control: Egg collection waste chicken epidermis
後述の実施例 3で調製した脱油ミンチ皮を 1 .  The deoiled minced skin prepared in Example 3 to be described later is 1.
を実施した。 その結果を纏めて表 4に示した。 Carried out. The results are summarized in Table 4.
表 4  Table 4
Figure imgf000019_0002
Figure imgf000019_0002
(構成比、含有率は質量%である。)  (The composition ratio and the content are mass%.)
上記 3例のムネ肉と決定的に異なる点は、 半分以上脱油処理済みにも拘 わらず、 総脂質が 1 0倍以上多く、 含有率は同レベルであるが総リ ン脂質 の占める割合が 1割以下に激減していること、 高次機能型では、 S M含有 量が 6倍程度に激増し、 総 P L型では P L— P Eが同レベルにあるのに対 して P L— P Cが 3質量0 /。台に激減していることで、 ムネ肉とは顕著に異 なつた結果であり、 組織特異性が極めて明瞭に出ていることが注目され る。 The crucial difference from the above 3 cases of meat is that the total lipid is more than 10 times, even though it has been deoiled more than half, and the content is the same, but the total phospholipid The proportion of SM is drastically reduced to 10% or less. In the high-order functional type, the SM content increases dramatically by about 6 times. In the total PL type, the PL-PE is at the same level. PC 3 mass 0 /. It is noteworthy that the result is a marked difference between the meat and the tissue specificity.
生表皮では、 総脂質含有量が、 少なく ともこの 3倍程度に跳ね上がるの で、 リン脂質類の含有率は一様に数分の一に著減する。  In the raw epidermis, the total lipid content jumps to at least about three times this, so the content of phospholipids decreases evenly by a fraction.
2 . 高次機能性リン脂質含有機能性ペーストの調製 2. Preparation of functional paste containing higher functional phospholipid
採卵鶏の廃鶏から採肉された脱気包装冷蔵の新鮮なムネ肉 (農事組合法 人工ヌチキン製) 、 好ましくは上記 1 . 2 ) 記載ミンチ 3 5 0 gに、 蛋白 質処理天然製剤 K O— X (久木野修 (いちき串木野巿下名 1126-1) 調製) 5 0 gを 2 5 0 m lの冷水に溶解させて、 冷蔵ミンチに加えて市販家電の フードプロセッサーで手早く混合し、 均一なペースト状態になったら調味 料 ·香辛料合わせて 3 4 . 3 gを加えて良く混合して調味済みムネ肉ミン チ 6 5 0 g (歩留り 9 5質量%) を得た。 これを脱気密封して冷蔵庫内で 数時間静置した。  Freshly evacuated packaged chilled meat (produced by the Agricultural Union Act, artificial nuchikin) taken from waste eggs from egg-laying hens, preferably 1.2) described in mince 3 550 g, protein-treated natural preparation KO— X (Prepared by Osamu Kukino (Ichiki Kushikino Nashina 1126-1)) Dissolve 50 g in 2 50 ml of cold water, mix with refrigerated mince, and quickly with a food processor of a commercial home appliance. Then, 34.3 g of seasonings and spices were added and mixed well to obtain 6500 g of seasoned fillet minced meat (yield 95% by mass). This was deaerated and sealed and left in the refrigerator for several hours.
3 . ムネ肉の凍結乾燥  3. Freeze drying of fillet
1 . 2 ) で調製 .包装 '保存した採卵廃鶏のムネ肉ミンチ 1 0 0 gを常 法通り、 市販の凍結乾燥装置で凍結乾燥を施して、 乾燥粉末ムネ肉 3 1 . 5 g (収率 9 8質量%) を得た。 実施例 2 プラズマローゲン型グリセ口リン脂質の濃縮と分離  1.2) Prepared by packaging (1) 100 g of minced minced chicken stock preserved in an ordinary manner and lyophilized in a commercial lyophilizer to obtain 31.5 g of dried powdered meat Rate 98% by mass). Example 2 Concentration and separation of plasmalogen-type glyceport phospholipids
1 . 廃鶏ムネ肉  1. Waste chicken fillet
廃鶏ムネ肉の実施例 1一 3 . 記載の方法で凍結乾燥した粉末 4 0 0 gを 、 抽出溶剤としてエタノール 1 0 0 O m Lを用いて抽出処理したのち、 抽 出液をロータリエバポレーターにより乾燥して、 総脂質 1 2 gを得た。 次いで、 この乾燥総脂質に、 その l g当たり、 2 0111 ]^の11ーへキサン /ァセトン (容量比 1Z 1 ) 混合溶剤を加え、 氷冷下に 1時間抽出処理し た。 その後、 抽出処理液を、 1 0 0 0 Gにて 1 0分間遠心処理して上清の 可溶部と沈殿物 (不溶部) を分離した。 次に、 可溶部をロータリエバポ レーターにより乾燥して得られた乾燥物に、 その l g当たり、 2 0mLの アセトンを加えて抽出処理した。 その後、 抽出処理液を、 1 0 0 0 Gにて 1 0分間遠心処理して、 上清の可溶部と沈殿物 (不溶部) を分離した。 不 溶部として、 スフインゴミエリンが除かれたリン脂質画分 8. 6 gが得ら れ、 その大部分はプラズマローゲン型グリセ口リン脂質 (4 5質量%) と P C · P Eの混合物 (4 5質量%) であった。 その HP L Cチャートを図 1に示し 7こ。 Example 1 of waste chicken fillet 3. Extraction of 400 g of freeze-dried powder using the method described above using 100 mL of ethanol as an extraction solvent, followed by extraction The effluent was dried by a rotary evaporator to obtain 12 g of total lipids. Then, the dried total lipids, per the lg, 2 0111] ^ 1 1 over hexane / Aseton (volume ratio 1Z 1) mixed solvent was added and 1 hour extraction process under ice cooling. Thereafter, the extraction solution was centrifuged at 100 G for 10 minutes to separate the soluble portion and the precipitate (insoluble portion) of the supernatant. Next, 20 mL of acetone per lg was added to the dried product obtained by drying the soluble part with a rotary evaporator, and extraction was performed. Thereafter, the extraction solution was centrifuged at 100 G for 10 minutes to separate the soluble portion and the precipitate (insoluble portion) of the supernatant. As an insoluble part, 8.6 g of a phospholipid fraction from which sphingomyelin was removed was obtained, most of which was a mixture of plasmalogen-type glyce mouth phospholipid (45 mass%) and PC · PE (4 5% by mass). The HP LC chart is shown in Fig. 1.
2. 有機育成採卵廃鶏のムネ肉  2. Fillet of organic breeding egg collection waste chicken
同上 1. と同様に凍結乾燥粉末 40 0 gを供試し、 分離総脂質 2 5 gか ら 1 0. 8 gのリン脂質画分を得た。 その H P L C測定結果 (図 2) から 主要成分は P L— P C + P L— P E ( 2 8質量%) と P C '( 5 3質量%) であることが示された。  In the same manner as in 1. above, 400 g of freeze-dried powder was used to obtain 10.8 g of phospholipid fraction from 25 g of the separated total lipid. The HPLC measurement results (Fig. 2) showed that the main components were P L—P C + P L—P E (28 mass%) and P C ′ (53 mass%).
3. プロイラ一種鶏雌雄の成鶏  3. Proila kind of adult chickens
1) ブロイラー種鶏雄の成鶏  1) Adult broiler chicken
実施例 1 1. 3 ) ( 1 ) で得られた総脂質 2 gを用いて、 実施例 2 1. と同様に濃縮 ·分離処理を行って濃縮リン脂質画分 1. 4 g (収率 7 0 %) を調製した。 この HP L C_ E L S D分析の結果、 [p i P C ( 7 0 %) + 1 P E ( 3 0 %) ] 0. 5 9 g (収率 4 2 %) 及ぴ [P C (9 4%) +P E ( 6 %) ] 0. 6 9 g (収率 4 9. 5 %) であることが判明 した。 2) 採卵鶏種鶏の廃鶏雌 Example 1 1. 3) Concentrated and separated in the same manner as in Example 2 1. using 2 g of the total lipid obtained in (1) to obtain a concentrated phospholipid fraction of 1.4 g (yield 7 0%) was prepared. As a result of this HP L C_ ELSD analysis, [pi PC (70%) + 1 PE (30%)] 0.5 9 g (yield 4 2%) and [PC (9 4%) + PE ( 6%)] 0.69 g (yield 49.5%). 2) Female laying hens
実施例 1 1. 3) (2) で得られた総脂質 2 gを用いて、 実施例 2 1. と同様に濃縮 ·分離操作を行って濃縮リ ン脂質画分 1. 2 7 g (収率 6 3. 7%) を調製した。 この H P L C/E L S D分析の結果、 [p l P C ( 6 0 %) +p 1 P E (4 0 %) ] 0. 4 5 g (収率 3 5. 3 %) 及ぴ [P C (9 0 %) +P E ( 1 0%) ] 0. 7 1 g (収率 5 5. 7 %) であ ることが判明した。  Example 1 1. 3) Concentrated and separated in the same manner as in Example 2 1. using 2 g of the total lipid obtained in (2). Rate 63.7%) was prepared. As a result of this HPLC / ELSD analysis, [pl PC (60%) + p1PE (4 0%)] 0.45 g (yield 35.3%) and [PC (9 0%) + It was found to be PE (1 0%)] 0.71 g (yield 55.7%).
4. 若鶏 (ブロイラー) のムネ肉 4. Broiler fillet
同上 1. と同様に凍結乾燥粉末 40 0 gを供試し、 分離総脂質 1 3. 5 gから 8. 7 gのリ ン脂質画分を得た。 その H P L C測定結果 (図 3) か ら主要成分は P C ( 6 0質量0 /0) と P L— P C + P L— P E ( 2 3質 量%) であることが示された。 実施例 3 高次機能性リン脂質含有機能性チキンミートボールの調製 In the same manner as in 1. above, 400 g of lyophilized powder was used to obtain a phospholipid fraction of 13.5 g to 8.7 g of separated total lipid. As HPLC measurement results (Fig. 3) or al major component was shown to be a PC (6 0 mass 0/0) and PL- PC + PL- PE (2 3 mass%). Example 3 Preparation of functional chicken meatballs containing higher order functional phospholipids
1 ) ミンチ化脱油した揉卵鶏廃鶏表皮の調製 1) Preparation of minced and deoiled eggs
採卵鶏の廃鶏から採取された新鮮表皮 5 0 0 g冷蔵品を前述装置で低温 下 8mmミンチ化し 4 7 0 g (収率 9 4質量%) の鶏皮ミンチを得た。 これ を高バリア性フィルム包材で真空パックして冷蔵保管した。 この鶏皮ミン チ 3 0 0 gを低酸素ハイブリッドスチーム加熱装置 (㈱タイヨ一製作所 ( 北斗巿清水川) 製; hi- L0HS装置) で 1 0 5°C 1 5分間低侵襲的に加熱脱 油して脱油鶏皮 8 mmミンチ 1 4 5 g (収率 4 8質量%) を得、 高バリア性 フィルム包材で真空パックして冷蔵保管した。  Fresh epidermis collected from waste chickens of egg-collecting hens was minced 8 mm under low temperature using the above-mentioned apparatus to obtain 4700 g (yield 94% by mass) of chicken skin mince. This was vacuum-packed with a high barrier film wrapping material and stored refrigerated. 300 g of this chicken skin minced is heated and deoiled minimally invasively at 105 ° C for 15 minutes with a low-oxygen hybrid steam heating device (made by Taiyoichi Seisakusho Co., Ltd. (Hito-Shimizugawa); hi-L0HS device). Thus, deoiled chicken skin 8 mm mince 14 45 g (yield 48 mass%) was obtained, vacuum-packed with a high barrier film packaging material, and stored refrigerated.
2) チキンミートボールの調製  2) Preparation of chicken meatballs
冷蔵調味済みムネ肉ミンチ 4 5 0 gに冷蔵脱油鶏皮ミンチ 5 0 gを加え て混合後に、 ミートボール成型装置付きフライヤ一 (1 7 0°CZ3分間) に供給して、 半揚げ状態の約 3 0 gのミートボール 4 5 0 g (収率 9 0質 量%) を得た。 この半揚げ状態のミートボール前記 hi- L0HS 1 1 5 °C 5 . 5分間加熱後に 5分間静置して余熱加熱を施して (図 4 ) 、 調理チキンミ 一トポール 4 2 0 g (収率 9 3質量%) を得た。 これを室温で放冷後に、 脱気包装冷凍保管した。 Refrigerated seasoned minced meat minced 45 5 g with chilled deoiled chicken skin minced 50 g After mixing, fryer with meatball molding device (1700 ° CZ for 3 minutes) To give about 30 g of meatballs 4550 g (yield 90 mass%) in a half-fried state. This half-fried meatball is heated at the above-mentioned hi-L0HS 1 1 5 ° C for 5.5 minutes, then left for 5 minutes and left to heat (Fig. 4). 3% by mass) was obtained. This was allowed to cool at room temperature, and then stored in a deaerated package frozen.
該冷凍調理済みチキンミートポール 1 0個 2 9 5 gを電子レンジ解凍 · 加温しドリ ップの副生なく 2 9 2 g (収率 9 9質量%) のホッ トチキンミ 一トポールが得られた。  The frozen cooked chicken meat poles 10 pieces 2 95 5 g were thawed and heated in a microwave oven, and 2 9 2 g (yield 99% by mass) of hot chicken meat tops were obtained without dripping. .
3 ) 冷凍 '解凍チキンミートボールの官能試験  3) Sensory test of frozen 'thawed chicken meatballs'
上記で得られたホッ トチキンミートポールを成人男女 1 2名で 2択形式 の官能試験を実施した。 表 2に示した様に、 高いスコアが得られた。 揚げ 物にしては油っぽくなく さっぱり として、 歯ぎわりがソフ トでジユーシー 、 鶏の味と香りがあって美味しいという感想が多かった。  The hot chicken meat pole obtained above was subjected to a two-choice sensory test with 12 adult men and women. As shown in Table 2, a high score was obtained. There were many impressions that the fried food was not oily and refreshed, and the texture was soft and juicy, and the taste and aroma of chicken were delicious.
表 5
Figure imgf000023_0001
Table 5
Figure imgf000023_0001
4 ) 冷凍チキンミートボールの成分分析 4) Component analysis of frozen chicken meatballs
冷凍チキンミートボールの脂質成分分析を行った。  Lipid component analysis of frozen chicken meatballs was performed.
表 6に示した様に使用原料由来のヒ ト型スフィンゴミエリンとプラズマ ローゲン型グリセロリン脂質のラズマローゲン型ホスフィチジルコリン及 びラズマローゲン型ホスファチジルェタノ一ルァミンが損耗せずに冷凍チ キンミートボール中に残存していることが明らかにされた。 表 6 As shown in Table 6, human sphingomyelin derived from the raw materials used, and the plasmalogen-type glycerophospholipid, lassmarogen-type phosphitidylcholine and lassmalogen-type phosphatidylethanolamine, were not worn out and were frozen chicken meatballs. It was revealed that it remained inside. Table 6
Figure imgf000024_0001
Figure imgf000024_0001
(構成比、含有率は質量%である。)  (The composition ratio and the content are mass%.)
産業上の利用可能性 Industrial applicability
本発明のリン脂質含有機能性素材及ぴプラズマローゲン型グリセ口リン 脂質の製造方法によれば、 機能性食品素材、 医薬品素材、 化粧品素材など として有用なリン脂質含有機能性素材及びプラズマローゲン型グリセ口リ ン脂質を、 簡単な操作で収率よく製造することができる。  According to the method for producing a phospholipid-containing functional material and a plasmalogen-type glycepore phospholipid of the present invention, a phospholipid-containing functional material useful as a functional food material, a pharmaceutical material, a cosmetic material, etc. Oral phospholipids can be produced with high yield by simple operations.

Claims

請求の範囲 The scope of the claims
1 . 家禽ムネ肉を、 ( a ) 低温 ·低酸素雰囲気下でのミンチ化工程、 ( b ) 乳化分散剤を用いた低温下でのペース ト化工程および ( c ) 低温乾燥 での粉末化工程の中から選ばれる少なく とも一つの工程によって形状変換 することにより、 リン脂質含有機能性素材を製造する方法であって、 ブラ ズマローゲン型グリセロリン脂質とスフィンゴミエリンとの合計量中の前 者の含有割合が 8 5質量。/。以上であり、 かつ総脂質中の全リン脂質の含有 割合が 4 0質量%以上であるリン脂質含有機能性素材を得ることを特徴と する、 リン脂質含有機能性素材の製造方法。  1. Poultry fillet (a) Mince process in low temperature and low oxygen atmosphere, (b) Paste process in low temperature using emulsifying dispersant, and (c) Powder process in low temperature drying A method of producing a phospholipid-containing functional material by converting its shape through at least one process selected from the above, wherein the content of the former in the total amount of plasmalogen glycerophospholipid and sphingomyelin There are 85 masses. /. A method for producing a phospholipid-containing functional material, characterized in that a phospholipid-containing functional material having a total phospholipid content in the total lipid of 40% by mass or more is obtained.
2 . 家禽ムネ肉が皮剥ぎムネ肉である請求項 1に記載の方法。 2. The method according to claim 1, wherein the poultry fillet is a peeled fillet.
3 . 家禽が成鶏 (以下、 廃鶏ということがある) であり、 かつプラズマ ローゲン型グリセ口リン脂質中のホスファチジノレコリンとホスファチジル エタノールァミンの構成比率において、 前者が 4 0質量%以上である、 請 求項 1または 2に記載の方法。  3. The poultry are adult chickens (hereinafter sometimes referred to as abandoned chickens), and the former is 40% by mass in the composition ratio of phosphatidinorecholine and phosphatidylethanolamine in plasmalogen glyce mouth phospholipids. The method according to claim 1 or 2 as described above.
4 . 家禽がブロイラー種鶏雌雄の成鶏であり、 かつプラズマローゲン型 ダリセロリン脂質中のホスファチジルコリンとホスファチジルエタノール ァミ ンの構成比率において、 前者が 5 0質量%以上である、 請求項 1また は 2に記載の方法。  4. The poultry are adult broiler chickens and males, and the former is 50% by mass or more in the composition ratio of phosphatidylcholine and phosphatidylethanolamine in plasmalogen-type darisserophospholipid. The method described in 1.
5 . 家禽がブロイラーであり、 かつプラズマローゲン型グリセ口リン脂 質中のホスファチジルコリンとホスファチジルエタノールアミンの構成比 率において、 後者が 5 0質量%以上である、 請求項 1または 2に記載の方 法。  5. The method according to claim 1 or 2, wherein the poultry is a broiler and the latter is 50% by mass or more in the composition ratio of phosphatidylcholine and phosphatidylethanolamine in the plasmalogen-type glyce mouth phospholipid. .
6 . ( A ) 家禽ムネ肉粉末から総脂質を抽出し、 乾燥処理する工程、 (B ) 前記 (A ) 工程で得られた乾燥総脂質を、 脂肪族炭化水素系溶剤と水溶 性ケトン系溶剤との混合溶剤で抽出処理し、 不溶部と、 プラズマローゲン 型グリセ口リン脂質を主体とする可溶部とに分離する工程、 (C) 前記 ( B) 工程で得られた可溶部を乾燥処理後、 水溶性ケトン系溶剤で抽出処理 し、 プラズマローゲン型グリセ口リン脂質を主体とする不溶部を分離回収 する工程、 を含むことを特徴とするプラズマローゲン型グリセ口リン脂質 の製造方法。 6. (A) Extracting total lipid from poultry fillet powder and drying (B) Dry total lipid obtained in step (A) is mixed with aliphatic hydrocarbon solvent and water-soluble ketone solvent. Extract with a mixed solvent with insoluble parts, and plasmalogen A step of separating the soluble part mainly composed of type glyceport phospholipid, (C) The soluble part obtained in the step (B) is dried and then extracted with a water-soluble ketone solvent, and plasmalogen And a step of separating and recovering an insoluble part mainly composed of type glyceport phospholipid, and a method for producing plasmalogen type glyceport phospholipid.
7. (B) 工程における混合溶剤が、 n キサンとアセ トンとを容量 比 4 : 6 6 : 4の割合で含み、 かつその使用量が、 乾燥総脂質 1 g当た り、 1 0 3 0 mLである請求項 6に記載の方法。  7. The mixed solvent in step (B) contains n-xane and acetone in a volume ratio of 4: 6 6: 4, and the amount used is 10 3 0 per 1 g of dry total lipid. The method according to claim 6, which is mL.
8. (C) 工程における水溶性ケトン系溶剤がアセトンであり、 その使 用量が、 (B) 工程で得られた可溶部の乾燥処理物 1 g当たり、 1 0 3 0 mLである請求項 6または 7に記載の方法。  8. The water-soluble ketone solvent used in step (C) is acetone, and the amount used is 100 mL per 1 g of the dried product of the soluble part obtained in step (B). The method according to 6 or 7.
9. 請求項 6 8のいずれか 1項に記載の方法を用いて得られたことを 特徴とするプラズマローゲン型グリセ口リン脂質。  9. A plasmalogen-type glyceport phospholipid obtained by using the method according to any one of claims 6 to 8.
PCT/JP2008/060120 2007-05-28 2008-05-27 Method for production of phospholipid-containing functional material, and method for production of plasmalogen-type glycerophospholipid WO2008146942A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009516384A JP5774816B2 (en) 2007-05-28 2008-05-27 Method for producing phospholipid-containing functional material and method for producing plasmalogen-type glycerophospholipid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-140046 2007-05-28
JP2007140046 2007-05-28

Publications (1)

Publication Number Publication Date
WO2008146942A1 true WO2008146942A1 (en) 2008-12-04

Family

ID=40075166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060120 WO2008146942A1 (en) 2007-05-28 2008-05-27 Method for production of phospholipid-containing functional material, and method for production of plasmalogen-type glycerophospholipid

Country Status (2)

Country Link
JP (1) JP5774816B2 (en)
WO (1) WO2008146942A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009154309A1 (en) * 2008-06-20 2009-12-23 有限会社梅田事務所 Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
WO2010047404A1 (en) * 2008-10-24 2010-04-29 有限会社梅田事務所 Method for producing functional dried material having room temperature storage stability or ground product thereof and extraction fraction of the material or the ground product, and use of the material, the ground product or the extraction fraction
WO2011083827A1 (en) * 2010-01-06 2011-07-14 株式会社レオロジー機能食品研究所 Cerebral nerve cell neogenesis agent
WO2012039472A1 (en) * 2010-09-24 2012-03-29 医療法人社団ブックス Drug against central nervous system inflammation
JP2017200466A (en) * 2016-05-02 2017-11-09 有限会社梅田事務所 Chicken breast meat-derived plasmalogen composition having improvement effects on cognitive function, preparation method thereof and processed foods for enhancing and/or improving cognitive function manufactured by adding the same
WO2017191838A1 (en) * 2016-05-02 2017-11-09 有限会社梅田事務所 Safe and stable plasmalogen, formulation thereof, and method for assessing presymptomatic state of dementia
CN109153693A (en) * 2016-05-02 2019-01-04 有限会社梅田事务所 The judgment method of the non-diseased state of safety-stable plasmalogen and its preparation and cognitive disorder
WO2019163856A1 (en) * 2018-02-21 2019-08-29 丸大食品株式会社 Method for producing phospholipid concentrate
WO2019171619A1 (en) * 2018-03-08 2019-09-12 日本薬品株式会社 Method for producing plasmalogen-containing composition
US10653708B2 (en) 2017-06-16 2020-05-19 Institute of Rheological Functions of Food Uses of ether phospholipids in treating diseases
US11066432B2 (en) 2014-12-08 2021-07-20 Institute of Rheological Functions of Food Ether phospholipids and method for producing the same
US11142537B2 (en) 2018-02-21 2021-10-12 Marudai Food Co., Ltd. Phospholipid concentrate manufacturing method

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60170700A (en) * 1984-02-15 1985-09-04 鈴木 康夫 Method of obtaining higher fatty acid
JPH03273096A (en) * 1990-03-20 1991-12-04 Sumitomo Seika Chem Co Ltd Method for extraction of lipid mixture
JPH0488963A (en) * 1990-08-02 1992-03-23 Sagami Chem Res Center Functional healthy food and feed
JPH09308459A (en) * 1996-05-20 1997-12-02 Nof Corp Nutritive composition containing highly unsaturated fatty acid
JP2001164286A (en) * 1999-12-10 2001-06-19 Nof Corp Oil composition
JP2004002663A (en) * 2002-03-29 2004-01-08 Shizuoka Prefecture Method for extracting lipid composition containing phospholipid with polyunsaturated fatty acid as constituent from fish internal organ
JP2005290308A (en) * 2004-04-05 2005-10-20 Q P Corp Method for producing phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition using the same
WO2008091015A1 (en) * 2007-01-26 2008-07-31 Umeda Jimusho Ltd. Process for producing sphingomyelin and plasmalogen-form glycerophospholipid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5350358A (en) * 1976-10-16 1978-05-08 Nippon Suisan Kaisha Ltd Method of producing process food
JPS59220168A (en) * 1983-05-27 1984-12-11 Taiyo Fishery Co Ltd Preparation of pasty protein food or protein ingredient
JPS61224966A (en) * 1985-03-28 1986-10-06 Techno Benchiyaa Kk Dried powdery food raw material made from undenaturated raw meat and production thereof
JPH01179667A (en) * 1988-01-06 1989-07-17 Toyo Jozo Co Ltd Paste product of low-fat meat and preparation thereof
JPH02145156A (en) * 1988-11-28 1990-06-04 Hosokawa Micron Corp Crushing method for food materials
JPH07250614A (en) * 1994-03-14 1995-10-03 Nippon Sanso Kk Method and apparatus for freezing rose-shaped minced food
JPH0970239A (en) * 1995-09-05 1997-03-18 Kazuto Hattori Poultry farming with saved energy by utilizing culled chicken regenerated with wild grass
JPH09275947A (en) * 1996-04-15 1997-10-28 Ito Ham Kk How to make a raw meat soup
JPH11103766A (en) * 1997-10-06 1999-04-20 Ishii Shokuhin Kk Production of chicken mince
JP2002045155A (en) * 2000-08-04 2002-02-12 National Food Research Institute A New Reducing Concentrated Extract with Storage Stability at Room Temperature and Its Manufacturing Method
WO2002042451A2 (en) * 2000-11-27 2002-05-30 Cytokinetics Aspergillus fumigatus cofilin
JP4712257B2 (en) * 2001-09-28 2011-06-29 東海物産株式会社 Processed chicken extract membrane and its contents
JP2004008188A (en) * 2002-06-04 2004-01-15 Asahi Broiler:Kk Snack food from chicken as raw material, having new palatability and taste and method for producing the same
JP4587649B2 (en) * 2002-08-27 2010-11-24 三栄源エフ・エフ・アイ株式会社 Processed meat
JP2004154028A (en) * 2002-11-05 2004-06-03 Ezaki Glico Co Ltd Method for producing roux

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60170700A (en) * 1984-02-15 1985-09-04 鈴木 康夫 Method of obtaining higher fatty acid
JPH03273096A (en) * 1990-03-20 1991-12-04 Sumitomo Seika Chem Co Ltd Method for extraction of lipid mixture
JPH0488963A (en) * 1990-08-02 1992-03-23 Sagami Chem Res Center Functional healthy food and feed
JPH09308459A (en) * 1996-05-20 1997-12-02 Nof Corp Nutritive composition containing highly unsaturated fatty acid
JP2001164286A (en) * 1999-12-10 2001-06-19 Nof Corp Oil composition
JP2004002663A (en) * 2002-03-29 2004-01-08 Shizuoka Prefecture Method for extracting lipid composition containing phospholipid with polyunsaturated fatty acid as constituent from fish internal organ
JP2005290308A (en) * 2004-04-05 2005-10-20 Q P Corp Method for producing phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition using the same
WO2008091015A1 (en) * 2007-01-26 2008-07-31 Umeda Jimusho Ltd. Process for producing sphingomyelin and plasmalogen-form glycerophospholipid

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FOGERTY A.C. ET AL.: "The composition of the fatty acids and aldehydes of the ethanolamine and choline phospholipids of various meats", INT. J. FOOD SCI. TECHNOL., vol. 26, no. 4, 1991, pages 363 - 371 *
FOGERTY A.C.: "Changes in the composition of the fatty acids and aldehydes of meat lipids after heating", INT. J. FOOD SCI. TECHNOL., vol. 25, no. 3, 1990, pages 304 - 312 *
KURODA N.: "Shokuhinchu no Plasmalogen Ganryo ni Tsuite", RES. BULL. OBIHIRO UNIV., vol. 9, 1975, pages 371 - 374 *
NAKANISHI T.: "Shokuniku no Rinshishitsu ni Kansuru Kenkyu", JAPANESE JOURNAL OF ZOOTECHNICAL SCIENCE, vol. 37, no. 1, 1966, pages 7 - 14 *

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009154309A1 (en) * 2008-06-20 2009-12-23 有限会社梅田事務所 Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
US8524282B2 (en) 2008-06-20 2013-09-03 Umeda Jimusho Ltd. Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
JP5430566B2 (en) * 2008-06-20 2014-03-05 有限会社梅田事務所 Method for producing high purity phospholipid and high purity sphingomyelin and plasmalogen glycerophospholipid obtained by the method
WO2010047404A1 (en) * 2008-10-24 2010-04-29 有限会社梅田事務所 Method for producing functional dried material having room temperature storage stability or ground product thereof and extraction fraction of the material or the ground product, and use of the material, the ground product or the extraction fraction
JP5656640B2 (en) * 2008-10-24 2015-01-21 有限会社梅田事務所 Method for producing room temperature storage-stabilized functional dried product or pulverized product thereof and extracted fraction thereof, and use thereof
WO2011083827A1 (en) * 2010-01-06 2011-07-14 株式会社レオロジー機能食品研究所 Cerebral nerve cell neogenesis agent
US8822437B2 (en) 2010-01-06 2014-09-02 Marudai Food Co., Ltd. Cerebral nerve cell neogenesis agent
JP6016363B2 (en) * 2010-01-06 2016-10-26 丸大食品株式会社 Cranial nerve cell neoplasia
WO2012039472A1 (en) * 2010-09-24 2012-03-29 医療法人社団ブックス Drug against central nervous system inflammation
JP5847086B2 (en) * 2010-09-24 2016-01-20 株式会社藤野ブレインリサーチ Anti-central nervous system inflammatory agent
US11066432B2 (en) 2014-12-08 2021-07-20 Institute of Rheological Functions of Food Ether phospholipids and method for producing the same
JP2018130130A (en) * 2016-05-02 2018-08-23 有限会社梅田事務所 Chicken breast meat derived plasmalogen composition and food composition containing the same for preventing forgetfulness related to language and situation of healthy subjects
WO2017191838A1 (en) * 2016-05-02 2017-11-09 有限会社梅田事務所 Safe and stable plasmalogen, formulation thereof, and method for assessing presymptomatic state of dementia
CN109153693A (en) * 2016-05-02 2019-01-04 有限会社梅田事务所 The judgment method of the non-diseased state of safety-stable plasmalogen and its preparation and cognitive disorder
CN109153693B (en) * 2016-05-02 2022-08-02 有限会社梅田事务所 Safe and stable plasmalogen, preparation thereof, and method for determining non-diseased state of cognitive disorder
JP2017200466A (en) * 2016-05-02 2017-11-09 有限会社梅田事務所 Chicken breast meat-derived plasmalogen composition having improvement effects on cognitive function, preparation method thereof and processed foods for enhancing and/or improving cognitive function manufactured by adding the same
US10653708B2 (en) 2017-06-16 2020-05-19 Institute of Rheological Functions of Food Uses of ether phospholipids in treating diseases
CN111757747A (en) * 2018-02-21 2020-10-09 丸大食品株式会社 Method for producing phospholipid concentrate
JP2019142818A (en) * 2018-02-21 2019-08-29 丸大食品株式会社 Phosphatide concentrate production method
US11091720B2 (en) 2018-02-21 2021-08-17 Marudai Food Co., Ltd. Method for producing phospholipid concentrate
US11142537B2 (en) 2018-02-21 2021-10-12 Marudai Food Co., Ltd. Phospholipid concentrate manufacturing method
WO2019163856A1 (en) * 2018-02-21 2019-08-29 丸大食品株式会社 Method for producing phospholipid concentrate
JP6653807B1 (en) * 2018-03-08 2020-02-26 日本薬品株式会社 Method for producing a composition containing a plasmalogen
WO2019171619A1 (en) * 2018-03-08 2019-09-12 日本薬品株式会社 Method for producing plasmalogen-containing composition
CN111757741A (en) * 2018-03-08 2020-10-09 日本药品株式会社 Method for preparing a composition containing a plasmalogen
US11517594B2 (en) * 2018-03-08 2022-12-06 Nihon Pharmaceutical Co., Ltd. Methods for producing compositions containing plasmalogen

Also Published As

Publication number Publication date
JPWO2008146942A1 (en) 2010-08-19
JP5774816B2 (en) 2015-09-09

Similar Documents

Publication Publication Date Title
JP5774816B2 (en) Method for producing phospholipid-containing functional material and method for producing plasmalogen-type glycerophospholipid
AU737567B2 (en) Sea cucumber carotenoid lipid fraction products and methods of use
AU2012364278C1 (en) Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof
US6399105B1 (en) Sea cucumber carotenoid lipid fraction products and methods of use
EP3131406A1 (en) Plant based meat structured protein products
JPWO2010035749A1 (en) Lipid concentration method
US20110160471A1 (en) Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
WO2009051470A1 (en) Flavour enhancers/food seasoning from seaweeds and a method for producing and uses thereof
KR20120105404A (en) Method for the preparation of oil-containing meat-based products comprising a reduced amount of additives
JP4358957B2 (en) Agent for scavenging or reducing free radicals or active oxygen
US4980185A (en) Method for making meat products having a reduced saturated fat and cholesterol content
JP5656640B2 (en) Method for producing room temperature storage-stabilized functional dried product or pulverized product thereof and extracted fraction thereof, and use thereof
US5116633A (en) Meat products having a markedly reduced saturated fat and cholesterol content and a markedly increased unsaturated fat content
JP5326246B2 (en) Muscle building agent
BRPI0619523A2 (en) meat and stock recovery process and products thereof
JP7021953B2 (en) Method for producing ether-type glycerophospholipid
JP2004516272A5 (en)
JP2002038183A (en) Method for producing sphingoglycolipid-containing substance
KR101337918B1 (en) Ell bone use composition for improvement of cholesterol
KR101248949B1 (en) Method for manufacturing of function chicken nuggets with containing extract of gang-hwa mugwort
TWI805800B (en) Compositions containing plasmalogens
JPH1084879A (en) Fraction of crude soybean lecithin having function to suppress synthesis of neutral fat in liver
AU2015100022A4 (en) Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof
JP6842093B2 (en) Learning memory enhancer
CN117860766A (en) Composition containing ether type glycerophospholipids and method for producing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08764969

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009516384

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08764969

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载